The Energy Code

In this week’s solo episode of The Energy Code, Dr. Mike Belkowski explores a major evolution in mitochondrial support: the transition from pharmacologic intervention to biological nourishment. Dr. Mike introduces BioBlue Aqua, a formula that replaces synthetic methylene blue with organic, high-purity blue spirulina to align with the body's natural evolutionary architecture. Dr. Mike unpacks the fundamental difference between "hacking" the system and "nourishing" the environment. While methylene blue acts as a powerful synthetic electron shuttle that can bypass damaged parts of the electron transport chain, blue spirulina (specifically the phycocyanin pigment) acts as a redox-train stabilizer. It supports the mitochondria by reducing upstream inflammatory signaling and protecting membrane integrity, allowing electron flow to normalize naturally. Whether you are looking for a daily, non-synthetic alternative to methylene blue or want to understand how deuterium-depleted water and trace minerals like colloidal gold and silver optimize your cellular voltage, this episode provides the blueprint for long-term terrain engineering. Key Topics Covered: The Evolution of Blue: Moving from synthetic methylene blue to biological mitochondrial nourishment. Energy as Electron Flow: Why mitochondrial voltage is the ultimate metric of health. Methylene Blue vs. Phycocyanin: Understanding the difference between an artificial electron shuttle and a redox stabilizer. The Purity of E40: Why organic sourcing and high absorbance ratios matter when using algae-derived pigments Layered Mitochondrial Support: The roles of NMN, Taurine, and Folic Acid in fueling and reinforcing cellular structures. Deuterium Depleted Water: How 10 ppm water reduces "isotopic drag" on the ATP synthase rotary motor. Choosing Your Tool: When to use methylene blue for acute intervention vs. blue spirulina for daily terrain optimization. Key Quotes from Dr. Mike: "Energy is not calories... Energy is electron flow." "Methylene blue behaves like a drug... Power and nourishment are different things." "Phycocyanin (in blue spirulina) does not override the electron transport chain. Instead, it improves the environment in which mitochondria operate." "When your target is mitochondrial voltage, introducing trace contaminants is counter-productive." "BioBlue Aqua is not a hack. It’s terrain engineering." Episode Timeline: 00:00 – Welcome to the Energy Code: Unlocking mitochondrial secrets 01:08 – Evolution vs. Departure: Introducing BioBlue Aqua 01:46 – The Foundation: Energy is electron flow, not just calories 03:23 – The Electron Transport Chain: How leakage drops mitochondrial voltage 05:19 – Methylene Blue Review: Synthetic power and the biphasic dose response 08:57 – Enter Blue Spirulina: The benefits of Organic E40 purity 12:13 – Mechanistic Differences: Artificial shuttles vs. redox stabilizers 14:24 – The Anti-Inflammatory Advantage: Protecting the terrain daily 16:09 – The Formula: NMN, Taurine, and Folic Acid roles 18:36 – Bioelectric Signaling: Colloidal gold, silver, and 10 ppm DDW 21:16 – Who should choose BioBlue Aqua? 22:07 – When is Methylene Blue the better choice? 24:52 – Closing Philosophy: Aligning with evolutionary architecture Special Offer: ⚡️ NEW RELEASE: 20% OFF BIOBLUE AQUA! ⚡️ For the next week, save 20% on your order of BioBlue Aqua! And for the next week ONLY, you can combine this 20% discount with the Subscribe and Save discount (choose on the product page when adding to cart). This limited-time offer provides you with a 30% discount on BioBlue Aqua and you will retain this exclusive discount of the lifetime of your subscription. Discount code: AQUA20 Expires on 3/26, midnight PST Stay Connected: Instagram: @dr.mikebelkowski LinkedIn: Dr. Mike Belkowski BioLight: Website

This Deep Dive isn’t about testing red light therapy in a lab, it’s about testing the information environment. A 2025 study analyzed how at-home red light therapy devices are promoted on Instagram and TikTok, and whether social media claims match what dermatology evidence can actually support. Using fresh accounts to reduce algorithm bias, researchers reviewed 132 posts with a combined potential reach of 47.5 million followers. Most content came from non-credentialed creators, and even when posts referenced “studies,” only a small fraction provided actual peer-reviewed citations. The takeaway: photobiomodulation is real — but online marketing often collapses dose-dependent biology into a shopping link, leaving consumers with overpromised outcomes and under-specified protocols. (Educational content only, not medical advice.) - Article Discussed in Episode: At-Home Red Light Therapy Devices: Promotion and Recommendation Patterns on Social Media in the Context of Limited Evidence - Key Quotes From Dr. Mike: “This paper isn’t testing red light therapy—it’s testing the information environment.” “Social media collapses all the nuance into a shopping link.” “Most posts said ‘research says’—but almost none showed the papers.” “The FDA label gets used like an efficacy stamp when it often isn’t.” “If the recommendation doesn’t include a real protocol, it’s not education — it’s marketing.” “This isn’t anti-red light therapy. It’s anti-confident misinformation.” - Key points Study analyzed 132 posts (75 IG, 57 TikTok) from late Jun–mid Jul 2025; potential reach 47.5M. 64.4% of posts came from non-credentialed accounts; physicians made 18.2%. Physician posts were fewer but carried 38.9% of total follower reach. TikTok skewed heavily non-credentialed (~87.7%), Instagram more mixed. Most recommended devices were Red + NIR (63.7%); multi-wavelength next (23.4%); red-only rare (~1.6%). Social media often treats wavelength as proof—but dose, irradiance, distance, time, and frequency drive outcomes. Prices ranged $7 to $159,500; median prices differed by credential group (non-credentialed lowest, licensed highest). Multi-wavelength “more is better” marketing can dilute effective output per band and doesn’t guarantee additive benefit. Skin benefits dominated (~88.6% of posts), but non-credentialed posts made much broader systemic claims. Many posts “referenced research,” but only 8.3% provided peer-reviewed journal articles. “FDA-cleared” is often misread as “FDA-proven effective”—clearance frequently signals safety/low risk, not efficacy for every claim. Clinician role: set expectations, clarify evidence tiers, teach dosing basics, and avoid amplifying commercial hype. - Episode timeline 0:19–1:55 — Premise: social media claims vs limited evidence; why this matters now. 1:55–3:20 — Methods: new accounts, search terms, timeframe, 132 posts, 47.5M reach. 3:20–5:20 — Credentials + influence: most non-credentialed; physicians smaller share but outsized reach; platform differences. 5:20–8:57 — Devices + pricing: red+NIR dominance; multi-wavelength trend; huge price range; “more wavelengths” myth. 9:00–11:56 — Claims: skin dominates; physicians narrower dermatology claims; non-credentialed expands into systemic promises. 10:50–12:51 — Evidence quality: only 8.3% cite peer-reviewed papers; mismatch between cited studies and marketed devices/protocols. 11:59–12:40 — FDA nuance: clearance ≠ proven efficacy for every claim. 12:53–16:40 — The modern pipeline: discovery → trust proxies → purchase → confusion → clinic. 16:40–18:28 — Consumer/clinician takeaways: demand protocols, set expectations, choose precision over hype. - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

What if the real upgrade in regenerative aesthetics isn’t a new injectable, it’s preconditioning the injectable? This Deep Dive breaks down a hypothesis-generating review proposing “mitochondria-targeted biophysical priming”: applying controlled physical energy (red/NIR light, ultrasound, mechanical cues) to autologous biologics inside a closed sterile system before injection. The idea is simple but disruptive: instead of delivering PRP/BMAC/SVF as-is, you deliver a biologic that’s been tuned for mitochondrial function, redox balance, and hostile microenvironments like photoaged skin and chronic wounds. It’s coherent, early, and not yet standardized; but it points to a future where potency is measured by mitochondrial metrics, not vibes. (Educational content only, not medical advice.) - Article Discussed in Episode: Mitochondria-Targeted Biophysical Priming of Autologous Biologics for Skin Regeneration and Wound Repair - Key Quotes From Dr. Mike: “Skin regeneration is an energy problem before it’s a cosmetic problem.” “Photoaging is mitochondrial dysfunction plus dysfunctional cleanup.” “The point isn’t ‘more energy.’ The point is signaling integrity: redox, mitophagy, inflammatory resolution, fibroblast behavior.” “Mitochondria are not a side character in skin, they’re the hub.” “Modern regenerative medicine isn’t adding more products — it’s designing better systems.” - Key points Skin aging + chronic wounds are mitochondria-driven (ROS, mtDNA damage, impaired OXPHOS, defective mitophagy). Autologous biologics (PRP/PPP, BMAC, SVF, MSC products) help, but outcomes are heterogeneous (prep methods, cell content, dosing, endpoints). The paper’s core proposal: prime the biologic ex vivo with physical energy before delivery. Goal: inject a biologic that’s metabolically tuned (ATP, membrane potential, redox, EV cargo). PBM can support fibroblast proliferation/migration and collagen signaling within a biphasic dose window (too much may inhibit). Priming is designed to happen in a closed system (sterility + minimal manipulation feasibility). For photoaging: PBM-primed PRP is hypothesized to preserve platelet mitochondrial function and optimize redox/EV profile. For chronic wounds: ultrasound/mechanical priming of BMAC/MSC fractions is hypothesized to enhance mitochondrial biogenesis/respiration and “pro-resolving” secretome. Mitochondrial transfer (via nanotubes/EVs) is plausible but not clinically proven as the main driver. Translation requires quality controls: ΔΨm, ATP, mtROS, mtDNA copy #, mitophagy/biogenesis markers + skin functional readouts. Regulatory reality: short, non-thermal priming without additives may fit minimal manipulation more than nanomaterial/e-field reprogramming. Bottom line: not “proven,” but a strategic direction—potency tuning via mitochondria + hard metrics. - Episode timeline 0:19–2:25 — Big thesis: prime PRP/BMAC/SVF in a closed system using biophysical energy to tune mitochondria. 2:52–7:16 — Why mitochondria matter in skin: UV/pollution/injury → ROS, mtDNA damage, impaired OXPHOS/mitophagy; chronic wounds as microenvironment failure. 7:29–12:45 — Autologous biologics overview: PRP/PPP and BMAC/MSC mechanisms + heterogeneity; mitochondrial modulation is plausible, not definitive. 12:51–18:06 — “Biophysical priming” defined + modalities: PBM, LIPUS/mechanics, experimental nano/tech approaches; biphasic dosing emphasized. 18:11–21:18 — Hypothesis scenarios: PBM-primed PRP (photoaging) and ultrasound/mech-primed BMAC (chronic wounds). 21:23–23:22 — Regulation + quality control: minimal manipulation boundaries; mitochondrial endpoints as potency metrics. 23:27–27:01 — Takeaway: mitochondria-targeted potency tuning is coherent, early, and needs standardized trials + hard metrics. - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Transcranial photobiomodulation (tPBM) is blowing up in performance culture, but what does the evidence actually say? In this Deep Dive, Dr. Mike Belkowski breaks down a narrative review (7 studies total: 5 human, 2 animal) examining tPBM in sports medicine for performance enhancement and injury prevention. You’ll learn the proposed mechanisms (mitochondrial respiration via cytochrome c oxidase, nitric oxide dynamics, calcium signaling), what the studies report across motor output, cognition, reaction time, grip strength, balance, and TBI recovery, and why the biggest limiter right now is protocol inconsistency + weak controls. The concept is compelling, but the science isn’t ready for absolute claims — especially in TBI. (Educational content only, not medical advice.) - Article Discussed in Episode: Transcranial Photobiomodulation in Sports Medicine: Enhancing Athletic Performance and Injury Prevention - Key Quotes From Dr. Mike: “If the brain is a performance organ, and it is, then brain energy is a legitimate target.” “tPBM follows a biphasic response — more is not always better.” “Treat tPBM as a complement to the real levers: sleep, rhythm, training, nutrition.” “If the bottleneck is sleep debt and overtraining, no headset can outshine that.” “The most honest conclusion here is: promising signal, weak standardization, and a field that needs better trials before bold claims.” - Key points tPBM = red/NIR light delivered through the scalp to influence CNS function (PFC, motor cortex, network hubs). Evidence base is early + small: 7 studies; only 1 double-blind sham-controlled RCT in the set. Core proposed target: cytochrome c oxidase → ATP support; also NO displacement → better oxygen utilization/redox. Potential downstream effects: blood flow + signaling (calcium, cAMP/NF-κB) → plasticity/repair pathways. Some studies show signals in motor output (e.g., finger tapping), and reported changes in reaction time/balance/grip (often uncontrolled). Cognition/sleep/mood improvements are reported, but many findings are vulnerable to placebo and expectation effects. Animal TBI models show delayed benefits (days 5–28) and reduced neuroinflammation/synaptic loss. Best-controlled human trial in persistent post-TBI symptoms found no significant advantage vs placebo after adjustments. tPBM is biphasic: dose matters; “more” can blunt effects — parameters define outcomes. Bottom line: tPBM is a promising adjunct tool, not a proven performance or TBI therapy yet; athletes need better trials and standardized protocols. - Episode timeline 0:19–1:32 — What tPBM is + evidence reality check (7 studies; early/mixed) 1:32–4:34 — Mechanisms: CCO/ATP, nitric oxide, calcium signaling → plasticity/inflammation 4:34–6:57 — Why it matters for sports + review selection + bias caveats 7:08–9:19 — Motor output signals (finger tapping; grip/balance claims + control issues) 9:19–10:23 — Cognition/sleep/mood: plausible, but often placebo-sensitive 10:23–12:09 — Animal TBI: delayed recovery benefits + anti-inflammatory shifts 12:09–14:20 — Human TBI: impressive case reports vs the sham-controlled null result 14:20–17:14 — Protocol variability + why there’s no standardized “athlete TPBM dose” 17:14–18:35 — Translation challenges (skull thickness, hair, targeting) + safety notes 18:35–23:00 — Bottom line: promising adjunct; not proven; what athletes should do with this info - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Alzheimer’s isn’t a sudden event. Rather, it’s a slow cascade that begins years (often decades) before symptoms present themselves. This Deep Dive explores a review positioning taurine as an early-phase, disease-modifying candidate — not as a miracle cure, but as a multi-target stabilizer that may support brain resilience upstream of major circuit loss. We break down why “single-target, late-stage” strategies struggle, how taurine may influence amyloid oligomers, mitochondrial stability, oxidative stress, calcium regulation, proteostasis/ER stress, neuroinflammation, and synaptic function, and why the real question is timing: early window vs. late-stage collapse. Promising, not proven. (Educational content only, not medical advice.) - Article Discussed in Episode: Taurine as an Early-Phase Disease-Modifying Candidate for Alzheimer’s Disease - Key Quotes From Dr. Mike: “Alzheimer’s is not one pathway. It’s converging pathologies that amplify each other.” “A multi-target molecule (i.e., taurine) isn’t a magic cure; it’s a stabilizer, especially early.” “Energy failure isn’t a side issue. It’s part of the disease engine.” “Neuroinflammation isn’t just a response, it can become a driver.” “The real future is likely combination: early detection plus multi-layer neuroprotection.” - Key points Alzheimer’s begins long before diagnosis; early neuroprotection may be the highest-leverage window. Taurine is endogenous, brain-concentrated, BBB-transported, and generally well tolerated. Alzheimer’s is a network failure (energy + inflammation + proteostasis + calcium + synapses), not one pathway. Taurine may modulate amyloid oligomers (often more toxic than plaques) and aggregation kinetics. Taurine is framed as a mitochondrial stabilizer (membrane potential, ATP support, less ROS signaling). It may buffer calcium and reduce excitotoxic load while preserving physiological signaling. It may tune ER stress / UPR and proteostasis rather than blunt adaptive stress responses. Anti-inflammatory potential includes taurine chloramine (TauCl) as a resolution-type feedback signal. Synaptic preservation matters more than plaque count; taurine may support plasticity markers/BDNF–CREB in models. Clinical Alzheimer’s evidence is still limited → best framing: promising, stage-dependent, needs trials. - Episode timeline 0:19–1:06 — Why this approach is “opposite” of mainstream: early-phase neuroprotection 1:06–3:20 — What taurine is + why it’s translationally attractive (BBB transport, safety history) 3:20–5:30 — Alzheimer’s as network collapse; limits of late single-target strategies 5:30–8:49 — Amyloid domain: oligomers vs plaques; taurine’s aggregation/oligomer modulation 8:49–12:59 — Mitochondria/ROS domain: stability, ATP support, less redox overload 12:59–15:28 — Proteostasis/ER stress domain + MAM/cross-talk framing 15:28–17:18 — Calcium/excitotoxicity + excitation/inhibition balance 17:18–19:06 — Neuroinflammation + TauCl as resolution-style mechanism 19:06–21:23 — Synaptic preservation + plasticity signaling (BDNF/CREB) 21:23–23:56 — Evidence breadth (models/organoids) + gaps and clinical limitations 23:56–27:25 — Take-home: stage-dependent strategy, resilience framework, “promising not proven” - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Microplastics and nanoplastics are now a near-constant modern exposure. This Deep Dive stays calm and scientific: detection is not causation, but detection across human tissues changes what’s plausible — and the paper builds a mechanistic map linking plastic particles to neurodegeneration-relevant biology through (1) gut barrier integrity, (2) microbiome + metabolites, (3) systemic immune activation and blood–brain barrier vulnerability, and (4) oxidative stress with nuclear + mitochondrial epigenetic reprogramming. The key theme isn’t panic, it’s resilience: reduce easy exposures without fear spirals, while building the biology that buffers stressors (sleep, circadian alignment, movement, metabolic stability, micronutrients, and gut health). (Educational content only, not medical advice.) - Article Discussed in Episode: Nuclear and Mitochondrial Epigenetic Mechanisms Underlying Neurodegeneration and Gut–Brain Axis Dysregulation Induced by Micro- and Nanoplastics - Key Quotes From Dr. Mike: “The question isn’t ‘should we panic?’ It’s ‘what does the science suggest, and how do we build resilience without hysteria?’” “Neuroinflammation doesn’t automatically mean neurodegeneration, but it lowers resilience.” “Epigenetic changes can persist after an exposure ends — they change the threshold for dysfunction.” “The biggest risk isn’t one exposure flipping a switch overnight; it’s chronic stressors lowering resilience over time.” “If the blood–brain barrier gets more permeable, the brain doesn’t just ‘feel’ inflammation — it inherits it.” - Key points Size is the story: microplastics (~1 µm–5 mm) vs nanoplastics (<1 µm) behave differently systemically. Main exposure routes: ingestion (food/water) + inhalation; skin contact may matter in some settings. Exposure science is messy: studies report particle count/size/shape vs mass, making real-world dosing hard. Detection ≠ causation, but detection in tissues/fluids changes plausibility of systemic distribution. Proposed 4-domain model: gut barrier → microbiome/metabolites → immune tone/BBB → oxidative + epigenetic remodeling. Barrier crossing is context-dependent: inflammation, dysbiosis, alcohol, sleep disruption, stress may increase permeability. Immune signaling shifts can activate NF-κB-type inflammatory programs and strain NRF2-type antioxidant defenses. Dysbiosis matters because metabolites are signals (SCFAs like butyrate; tryptophan/indole metabolites; bile acids). Epigenetics is the “memory layer”: changes in methylation/histones/microRNAs can persist after exposure. Mitochondria are a key convergence point: oxidative stress can disrupt membrane potential, cristae, OxPhos, and stress responses like mitophagy. Practical frame: don’t obsess over one exposure — raise baseline resilience and reduce easy exposure sources. - Episode timeline 0:19–1:20 — Frame: non-hysterical resilience + core mechanistic map 1:17–2:33 — Definitions + exposure routes + why dose comparisons are hard 2:37–3:55 — Tissue detection: why it matters (without claiming causation) 4:04–6:23 — Domain 1: gut barrier integrity + size/context-dependent uptake 6:23–7:24 — Domain 2: immune activation (NF-κB / NRF2 framing) 7:24–10:27 — Domain 3: microbiome shifts → metabolite signaling → resilience 10:27–13:50 — Domain 4: nuclear + mitochondrial epigenetic remodeling + oxidative stress convergence 13:50–15:10 — What the paper doesn’t claim + why properties/co-exposures matter 15:14–18:43 — Practical “Energy Code” takeaways: reduce easy exposures + build baseline resilience - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Most people think circadian rhythm is just sleep hygiene. This deep dive shows it’s metabolic infrastructure. In a hepatocyte-specific BMAL1 knockout mouse model, skeletal muscle clock genes kept oscillating — but a huge slice of muscle metabolic rhythms didn’t. Roughly 1/3 of rhythmic muscle genes were re-tuned when the liver clock was disrupted, and the biggest hit landed on mitochondrial respiration: over half of oscillatory oxidative phosphorylation genes changed. Even more compelling, serum transfer experiments showed the liver clock helps deliver a nighttime endocrine “upshift” signal that primes muscle cells for oxidative phosphorylation and ATP output. Translation: when circadian timing breaks, your organs stop cooperating and that “random fatigue” can be a timing problem, not a motivation problem. (Educational content only, not medical advice.) - Article Discussed in Episode: The liver clock tunes transcriptional rhythms in skeletal muscle to regulate mitochondrial function - Key Quotes From Dr. Mike: “The liver is not just a metabolic organ, it’s a timing organ.” “Your liver’s internal clock isn’t just running liver chemistry, it’s tuning mitochondrial function in skeletal muscle.” “About one third of rhythmic muscle genes are influenced by the liver clock.” “If your clocks are misaligned, your organs stop cooperating and the symptoms look like fatigue, cravings, and poor recovery.” “Longevity and performance aren’t only about what you do — they’re about when you do it.” - Key points Liver clock ≠ muscle clock control: muscle core clock rhythms stayed largely intact even when hepatocyte BMAL1 was deleted. But the liver clock tunes muscle metabolism: ~30.5% of rhythmic muscle genes shifted with liver clock disruption. Rhythmic gene changes split into: ~14.7% lost oscillation, ~14.1% gained oscillation, ~1.7% changed phase/amplitude. Carb metabolism rhythms were most resilient (~85.2% unaffected). Lipid metabolism rhythms were more sensitive (~26.9% affected). Mitochondrial programs were hit hardest: ~35.8% of mitochondrial envelope rhythmic genes affected. OxPhos was the headline: ~58.3% of oscillatory oxidative phosphorylation genes were affected. Active-phase serum is the signal carrier: WT night serum upregulated ribosomal + OxPhos genes in myotubes. Liver clock disruption breaks the night signal: ZT16 serum from knockout mice altered 136/210 serum-responsive genes vs WT. Functional readout matched: myotubes treated with knockout dark-phase serum showed lower ATP production(Seahorse). Practical translation: circadian alignment = organ cooperation, and “energy dips” may reflect mistimed endocrine signaling. - Episode timeline 0:19–1:40 — The thesis: circadian rhythm + liver + muscle mitochondria are one network 1:42–3:12 — Circadian basics + BMAL1 as the non-redundant clock driver 3:15–4:55 — Model: hepatocyte-specific BMAL1 knockout; muscle clock genes largely intact 5:00–6:20 — The headline: ~30.5% of rhythmic muscle genes shift with liver clock disruption 6:20–9:30 — Pathway impacts: carbs resilient; lipids sensitive; OxPhos heavily affected (~58.3%) 9:41–12:45 — Serum transfer experiments: WT night serum induces OxPhos/ribosome genes; knockout night serum breaks it 13:33–14:30 — Function test: Seahorse shows lower ATP production with knockout dark-phase serum 16:00–18:45 — What might the signal be? hepatokines, metabolites, EVs; secretion machinery may be altered 19:35–22:53 — Practical takeaways: timing as infrastructure; meal timing + morning light; energy dips as timing problem 22:53–23:15 — Close: “not just what you do — when you do it” - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Photobiomodulation (PBM) and low-level light therapy (LLLT) are everywhere, and so are the claims: more ATP, better recovery, fat loss, nervous system balance, strength gains… all from the same “red light” buzzword. In this 3-paper masterclass, Dr. Mike Belkowski breaks the hype down into evidence, endpoints, and bottlenecks. You’ll get a clean, practical analysis of three very different PBM applications: Body circumference reduction (systematic review of sham-controlled RCTs) Autonomic nervous system regulation using HRV after infra-auricular/vagus-region PBM (randomized controlled trial) Upper-body performance on a real-world compound lift (bench press) in collegiate athletes (double-blind repeated-measures) Then we connect the dots: why PBM can show a strong signal in one domain, a weak signal in another, and no signal at all when the limiting factor isn’t mitochondrial energy; but coordination, sleep, stress, or recovery terrain. Bottom line: light is real, but its application is not universal — it works when the tool matches the job. (Educational content only, not medical advice.) - Articles Discussed in Episode: The influence of photobiomodulation on upper body muscular performance in collegiate athletes Effects of Acute Photobiomodulation on Heart Rate Variability in Physically Active Individuals: A Randomized and Controlled Clinical Trial Low-level laser therapy for reducing body circumferences: a systematic review - Key Quotes From Dr. Mike: “The PBM trap is thinking ‘more ATP’ automatically means better everything.” “Light therapy is real, but real does not mean universal. It means context-dependent.” “HRV is a moving target — sleep, caffeine, hydration, stress can drown out small effects.” “If you want nervous system balance, the big levers are still sleep, rhythm, breath, and training load.” “Ask better questions: what tissue, what depth, what dose, what endpoint?” - Key points PBM is a signal, not a guarantee → Match the tool to the job. Paper 1 (LLLT body contouring): short-term circumference reductions beat sham; high satisfaction; good tolerability; only 3 RCTs → promising but early. Devices/wavelengths varied (e.g., 532 nm, 635 nm, 635–680 nm) → can’t yet define “best protocol.” Follow-up windows were short (weeks) → durability still unknown long-term. Mechanism proposed: adipocyte emptying/pores (adipocytolysis / lipid peroxidation) more than guaranteed fat-cell death → lifestyle may determine persistence. Paper 2 (HRV/vagus-region PBM): acute 660 nm infraauricular PBM showed minimal HRV changes in healthy active adults; one entropy metric differed. HRV is a noisy systems output influenced by many variables; acute PBM may be underdosed or target too indirect. Paper 3 (bench press): PBM did not beat sham for 1RM, volume load, or soreness; baseline-to-week improvement likely learning/familiarization, not light. As movement complexity increases, PBM’s effect may drop if the limiter is coordination/neural drive, not local muscle energetics. Core takeaway: PBM efficacy is bottleneck-dependent—hit the bottleneck, see signal; miss it, see nothing. - Episode timeline 0:02–1:58 Setup: PBM isn’t magic—3 papers, 3 targets, 3 outcomes 1:59–14:48 Paper 1: LLLT body circumference systematic review (signal + limits) 15:19–21:47 Paper 2: Vagus-region PBM + HRV trial (mostly null; why that matters) 22:15–28:57 Paper 3: Bench press performance trial (PBM vs sham; no advantage) 29:01–35:19 Compare/contrast: endpoints, bottlenecks, evidence strength, mechanism chain length 35:38–37:23 Practical decision framework by goal (contouring vs HRV vs compound strength) 37:31–39:55 Final thesis: PBM works sometimes — context, dose, and bottleneck decide - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Reproductive aging isn’t just your birthday — it’s biology. In this Deep Dive, Dr. Mike Belkowski breaks down the emerging science of AI in fertility assessment and why the next wave of reproductive medicine will move beyond single-marker thinking (AMH, FSH, AFC, semen analysis) into a multi-dimensional model built on three interconnected pillars: mitochondrial function, oxidative stress, and telomere biology. You’ll learn why egg and sperm quality decline is fundamentally an energy and redox story, why the most meaningful biomarkers are often hard to use clinically (invasive, destructive, non-standardized), and how AI can realistically change the game through imaging, pattern recognition, and multi-omics integration — without replacing clinicians. We also cover the real-world constraints: data quality, bias, explainability, validation, regulation, and privacy; because the future isn’t hype, it’s precision. (Educational content only, not medical advice.) - Article Discussed in Episode: Artificial Intelligence in Assessing Reproductive Aging: Role of Mitochondria, Oxidative Stress, and Telomere Biology - Key Quotes From Dr. Mike: “Fertility decline happens at the level of energy, oxidative stress, and cellular timekeeping.” “Oocytes are an ATP-intensive cell type; energy is the limiting factor.” “ROS isn’t the villain—uncontrolled ROS is the villain.” “Mitochondria, oxidative stress, and telomeres aren’t separate — they amplify each other.” “AI won’t replace clinicians—it can integrate complexity humans can’t.” “The next frontier is multi-layer prediction: hormones + imaging + mitochondrial competence.” - Key points Reproductive aging is biological, not just chronological. The “big 3” drivers: mitochondrial dysfunction + oxidative stress + telomere dynamics. Standard markers (AMH/FSH/AFC; semen analysis) don’t fully predict gamete quality/outcomes. Oocytes are mitochondria-dense; ATP is required for spindle formation, segregation, fertilization, early development. Sperm rely on mitochondria for motility, capacitation, DNA integrity. Mitochondrial biomarkers: mtDNA copy number, membrane potential, ATP, ROS—but many tests are invasive/destructive. ROS is necessary at physiologic levels; excess ROS drives DNA/lipid/protein damage and reproductive decline. Telomeres: shorter telomeres correlate with worse female outcomes; male telomere dynamics differ, but oxidative stress still harms telomeres/DNA. These pillars amplify each other: mito dysfunction → ROS ↑ → telomere damage ↑ → cellular aging ↑. AI’s current traction: embryo grading, IVF outcome prediction, computer-vision sperm analysis. Next frontier: AI integrating hormones + imaging + mitochondrial/oxidative/telomere biomarkers + lifestyle/exposures. Adoption requires explainability, multi-center validation, bias control, privacy, and clear accountability. - Episode timeline 0:19–2:29 Why AI is about to reshape fertility assessment + the 3 pillars framework 2:46–5:32 Mitochondria in eggs/sperm + key mito biomarkers + why testing is hard clinically 5:37–7:42 Oxidative stress: why ROS is both necessary and dangerous + biomarkers + standardization issues 7:42–9:33 Telomeres: female vs male dynamics + the amplification loop (mito ↔ ROS ↔ telomeres) 9:43–11:23 Where AI already works: embryo grading, IVF prediction, sperm analysis + what’s next 11:23–12:34 Real-world constraints: explainability, bias, heterogeneity, validation, regulation, privacy 12:37–15:28 The Energy Code takeaway: fertility as “energy age” + personalized levers + responsible precision 15:35–16:15 Tease: what a next-gen AI fertility clinic could look like - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Most people treat scars like an aesthetic afterthought, but hypertrophic scars and keloids are biologically active tissue: itchy, painful, stiff, inflamed, and often stubbornly persistent. In this Energy Code Deep Dive, Dr. Mike Belkowski breaks down a randomized double-blind clinical trial using a synergistic 3-part approach: microneedling + photodynamic therapy + methylene blue as the photosensitizer. We walk through the exact protocol (5 weekly sessions), how results were measured (JSS + POSAS), and what actually improved — thickness, stiffness, pain, itching, flexibility, pigmentation, vascularity, and patient satisfaction. We also discuss why controlled ROS under photodynamic therapy is different from chronic oxidative stress, why keloids may respond better to 1% methylene blue, and what “resetting the remodeling environment” really means. (Educational content only, not medical advice.) - Article Discussed in Episode: Redefining scar quality: A synergistic approach with micro-needling and photodynamic therapy using methylene blue as a photosensitizer: a randomized clinical trial - Key Quotes From Dr. Mike: “Scars aren’t just leftover tissue... they’re often biologically active.” “Microneedling opens the pathway. Light delivers the signal. Methylene blue is the photochemical tool.” “ROS (reactive oxygen species) isn’t ‘bad’— chronic ROS is bad. Controlled ROS can be therapeutic.” “If you want to change tissue outcomes, you often have to change the tissue environment.” “Methylene blue isn’t just a ‘mitochondria molecule'. In the right context, it’s a precision photochemical lever.” - Key points Scars are biology, not just cosmetics; keloids/hypertrophic scars can stay inflamed and symptomatic. Trial design: randomized double-blind; 37 patients / 94 scars; 5 sessions, weekly. 4 groups: keloid vs hypertrophic × 0.1% vs 1% methylene blue. Protocol: microneedling (≈1–3 mm) → apply MB → occlude 30 min → light 15 min. Measured with JSS + POSAS (clinician + patient symptoms). Severity drop: JSS score fell roughly 14.69 → 4.69 by 6 months. POSAS: ~50% improvement after treatment; stable through 6 months. Biggest symptom wins: stiffness ↓ ~71%, itching ↓ ~70%, pain ↓ ~69%. 1% MB tended to outperform 0.1% for keloids (stronger photosensitizing effect/penetration). Low adverse events; keloid recurrence ~2% at 6 months; none reported for hypertrophic scars in that window. Mechanism logic: microneedling “restarts remodeling” + MB-PDT generates targeted ROS to modulate fibroblasts/collagen/inflammation. Limitations: small sample, no untreated control, subjective scales, limited objective imaging, follow-up only 6 months. - Episode timeline 0:19–1:31 Why scars are biology + the 3-part stack (microneedling + PDT + methylene blue) 1:36–2:17 Hypertrophic vs keloid + why standard care struggles (recurrence/side effects) 2:20–4:25 Trial setup: 37 patients / 94 scars, 4 groups, 5 weekly sessions + parameters 4:25–5:03 Outcomes measured: JSS + POSAS (clinician + patient symptoms) 5:05–6:13 Results: big drops in severity + symptom relief (stiffness/itching/pain) 6:13–7:37 Dose logic: 1% vs 0.1% MB + “controlled ROS” explanation 7:44–9:48 Mechanism: fibroblasts/collagen remodeling + why the combo is synergistic 9:51–10:48 Safety + recurrence + limitations (and what future trials need) 11:00–14:18 BioLight philosophy: stacking inputs, changing the environment, next steps - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

This episode is a graduate-seminar style scholarly review of biohacking; not as a vibe or a shopping list, but as an ecosystem of claims, evidence types, incentives, and failure modes. Dr. Mike Belkowski walks through peer-reviewed biochemical arguments, academic frameworks, consumer books, surveys, mainstream media translation, and manifesto-style writing — then filters it all through one lens: mitochondria, redox balance, inflammation control, cellular cleanup, and the upstream metabolic terrain that determines whether “hacks” create resilience or just add noise. You’ll learn why changing 12 variables at once isn’t a protocol (it’s a story), why wearables are dashboards (not engines), how constraints like sleep and circadian rhythm govern everything downstream, and how to use evidence-tiering to separate real effects from compelling narratives. The end result is a practical, mitochondria-first framework: define outcomes, stabilize the baseline, add one lever at a time, and let measurement be the referee... not your identity. (Educational content only, not medical advice.) - Key Quotes From Dr. Mike: ​“Biohacking is not one discipline, it’s an ecosystem.” “You can feel like you’re doing a lot while actually destabilizing your physiology.” “People change too many variables too quickly — they never stabilize long enough to see what’s helping.” “The stress of tracking becomes a biological stressor.” “A real biohack improves the slope of recovery and the durability of function.” - Key points Biohacking is an ecosystem, not a single discipline; it contains truth, hype, and ideology. The scholarly move: classify claims by mechanism, evidence type, and limits. Real “biohacking” = shifting upstream terrain (metabolic state), not adding tricks. City analogy: fix the power grid (mitochondria/redox/inflammation) before buying “better cars” (more tools). Maximalist stacks (12 changes at once) create stories, not causal protocols. Health is constrained by fundamentals: sleep, circadian rhythm, movement, nutrients, stress load. Wearables are dashboards: they inform iteration, but don’t change the engine by themselves. Surveys show adoption truth: protocols must be sustainable (time/cost barriers matter). Media rewards novelty → often overemphasizes shortcuts and underemphasizes constraints. Manifesto writing can weaponize mitochondrial language into overconfident worldviews. Common failure modes: novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness. Use evidence tiers to guide safety and precision (don’t treat anecdotes like RCTs). Build a stack like a scientist: one goal, few metrics, one variable at a time. A “real stack” is earned through validated iteration, not purchased. - Episode timeline 0:02–1:31 — Setup: “scholarly review” of biohacking through a mitochondria-first lens; sources overview 1:31–4:57 — Biohacking = ecosystem; classification; metabolic terrain + “city/grid” analogy 4:57–8:15 — Maximalist stack critique; constraints; dashboards vs engines; measurement vs entertainment 8:15–10:52 — Consumer books + surveys + media framing: adoption, hype incentives, sustainability 10:52–12:57 — Manifesto layer: how mitochondria language can out-run evidence 12:57–14:49 — Failure modes (novelty addiction, metric worship, evidence flattening, baseline neglect, context blindness) 14:49–19:47 — Evidence-tiering + what “effectiveness” really means (subjective → functional → biomarkers → long-term) 19:47–23:04 — Practical method: define outcome, simplify metrics, fix terrain, add one lever, evaluate humbly, build stack 23:04–26:59 — Personas + closing thesis: biohacking works when it respects biology, evidence, dose, context, and constraints - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Traumatic brain injury isn’t just the impact, it’s the secondary injury cascade that follows: swelling, inflammation, oxidative overload, mitochondrial dysfunction, and immune activation that won’t shut off. In this Deep Dive, Dr. Mike Belkowski unpacks a mouse-model study where methylene blue was associated with better outcomes across multiple layers of that cascade: reduced early brain edema, improved acute neurological scores, smaller lesion volume over time, and greater neuronal survival. Then we go deeper into the “Energy Code” mechanisms: microglial activation (the brain’s immune cleanup crew that can become chronically destructive), autophagy (cellular cleanup that clears damaged parts after trauma), and why damaged mitochondria can lock the brain into an inflammation ↔ mitochondrial damage loop. The big message: brain injury is an energy crisis, and strategies that stabilize mitochondrial function, support cleanup, and improve resolution may shift the recovery trajectory. (Educational content only, not medical advice.) - Article Discussed in Episode: Methylene blue exerts a neuroprotective effect against traumatic brain injury by promoting autophagy and inhibiting microglial activation - Key Quotes From Dr. Mike: “Pressure inside the skull is like trying to run a high-performance engine while someone steps on the fuel line.” “If microglia stay activated too long, they can become the thing that keeps the injury going.” “Damaged mitochondria drive inflammation. Inflammation drives more mitochondrial damage.” “This is why a mitochondrial-first model of brain resilience makes sense.” “The goal isn’t to eliminate ROS—the goal is to prevent chronic overload and restore redox balance.” - Key points TBI damage expands through secondary injury (swelling, inflammation, oxidative stress, mitochondrial failure, BBB disruption). Swelling = pressure, pressure compromises blood flow/oxygen → brain energy crisis. In a mouse TBI model, methylene blue was associated with: Less edema ~24h Better neuro scores at 24h and 72h Smaller lesion volume at 24h, 72h, and 14d More neuronal survival early Microglia: essential responders, but chronic activation becomes collateral damage. Methylene blue was associated with reduced microglial activation at 72h and 14d. Autophagy = cellular maintenance; after injury, cleanup becomes survival. Study showed markers consistent with higher autophagy activity acutely with methylene blue. Damaged mitochondria amplify inflammation; inflammation further damages mitochondria → self-perpetuating loop. “Mitochondria-first” recovery lens: improve energy efficiency, reduce oxidative overload, support resolution. Stack mindset: light (PBM), sleep/circadian timing, nutrient status shape recovery capacity. Antioxidants aren’t “more is better”; goal is redox balance, not zero ROS. - Episode timeline 0:19–1:42 — Frame: TBI + methylene blue; secondary injury explained 1:42–3:40 — Outcomes: edema ↓, neuro scores ↑, lesion volume ↓, neuronal survival ↑ 3:40–4:59 — Microglia: acute defense vs chronic damage; MB association with reduced activation 4:59–6:20 — Autophagy as cleanup; MB association with increased acute cleanup signaling 6:20–7:40 — Why mitochondria matter: ROS/inflammation loop; MB as mitochondrial efficiency concept 7:40–9:18 — Stack thinking: PBM/light + resolution framing + fundamentals (sleep/circadian/nutrients) 9:18–11:13 — Redox realism + big takeaway: TBI = energy crisis; aging parallels; close - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Alzheimer’s is usually framed as plaques and tangles—but this Deep Dive goes upstream: mitochondrial failure and impaired mitophagy. Dr. Mike Belkowski breaks down mitophagy as the brain’s selective mitochondrial cleanup system—and why neurons are uniquely vulnerable when damaged mitochondria can’t be transported, tagged, and fully degraded. You’ll learn how mitophagy appears impaired across multiple steps in Alzheimer’s (initiation, recruitment, transport, lysosomal fusion, and degradation), how hallmark factors like tau, amyloid-beta, APP fragments (APP-CTFs), and APOE4 can jam the machinery, and why the real therapeutic target may be mitophagy flux—not just turning the process “on,” but ensuring cleanup completes from start to finish. The episode closes with a systems-based framework for breaking the loop: reduce chronic stressors, support mitochondrial signaling, and prioritize lifestyle levers that promote mitochondrial quality control. (Educational content only, not medical advice.) - Article Discussed in Episode: Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches - Key Quotes From Dr. Mike: “Alzheimer’s isn’t just plaques and tangles — it’s also a story about energy failure.” “Mitophagy is selective mitochondrial cleanup.” “If you don’t remove broken mitochondria, they don’t sit quietly—they leak.” “You can’t just ask, ‘Is mitophagy turned on?’ You have to ask, ‘Is mitophagy completing?’” “Damaged mitochondria accumulate → more oxidative stress → more energy failure → worse cleanup.” “The future isn’t just ‘turn on mitophagy.’ It’s support mitophagy flux from start to finish.” - Key points Mitophagy = selective mitochondrial cleanup (tag → wrap → lysosome → recycle). In neurons, cleanup is harder: lysosomes are mainly in the soma, so damaged mitochondria in axons must be transported back. In Alzheimer’s, damaged mitochondria accumulate, especially near synapses → ROS, calcium disruption, inflammation, ATP loss. Evidence summarized: Alzheimer’s brains show reduced mitophagy signatures + structurally damaged mitochondria (cristae disruption, low ATP). Mitophagy impairment can occur at multiple failure points (initiation → LC3 recruitment → AMPK/ULK1/TBK1 signaling → lysosomal fusion). Key principle: initiation ≠ completion; if lysosomal fusion fails, you get “garbage bags with no pickup.” Transport deficits (incl. DISC1-related trafficking roles) can worsen mitochondrial congestion. Alzheimer’s proteins can jam mitophagy: tau (PINK1/Parkin interference), amyloid-beta (context-dependent; flux often blocked downstream). APP-CTFs may correlate strongly with mitophagy marker changes and may disrupt mitochondria-associated membranes (MAMs). APOE4 links to autophagy/lysosomal dysfunction, a major bottleneck for clearance. Therapeutic direction: not just “boost mitophagy,” but support mitophagy flux + lysosomal capacity + brain penetration. Biggest levers aren’t only compounds—exercise, fasting-style metabolic stress, rhythm/sleep are core mitophagy signals; chronic stressors crush it. - Episode timeline 0:19–1:45 — Frame: Alzheimer’s as energy + cleanup failure; define mitophagy 1:45–2:45 — Neuron logistics: soma lysosomes, axonal transport, synaptic vulnerability 2:45–4:20 — Evidence: impaired mitophagy markers + damaged mitochondria; “completion vs initiation” 4:20–5:15 — Transport issues (DISC1) and multi-step failure points 5:15–8:15 — Mapping AD factors to mitophagy failure: tau, amyloid, APP-CTFs/MAMs, APOE4 8:15–9:40 — The vicious loop (mitochondria ↔ ROS ↔ inflammation ↔ clearance failure) 9:40–11:35 — Breaking the loop: flux-first strategy; compounds under investigation; bottlenecks 11:35–14:10 — Lifestyle levers + Biolite “mitochondria stack” framing; systems-based takeaway - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Mitochondria aren’t isolated “batteries”... they’re sensors responding to your light exposure, diet, sleep, stress, inflammation, toxins, and microbiome. In this Deep Dive, Dr. Mike Belkowski unpacks a powerful emerging framework: the gut–extracellular vesicle–mitochondria axis—how microbial metabolites and tiny biological “delivery packages” (EVs) can travel through the body and influence mitochondrial efficiency, oxidative stress, inflammation, senescence, and tissue resilience. Using reproductive aging as the case study (one of the earliest mirrors of biological age), we zoom out to show why this axis likely impacts systemic aging, brain health, metabolic health, recovery, and longevity. You’ll learn how signals like urolithin A, butyrate, indole compounds, and polyphenol metabolites interact with mitochondrial quality control; and why the real goal isn’t “eliminating ROS,” but restoring redox intelligence and breaking the chronic loops that accelerate aging. (Educational content only, not medical advice.) - Article Discussed in Episode: The Gut–Extracellular Vesicle–Mitochondria Axis in Reproductive Aging: Antioxidant and Anti-Senescence Mechanisms - Key Quotes From Dr. Mike: “If you’re not feeding your microbiome, you’re missing a major upstream lever for mitochondrial health.” “Mitophagy is a clean-up process that helps maintain mitochondrial quality.” “ROS damages mitochondria. Damaged mitochondria produce more ROS.” “Mitochondria aren’t just energy—mitochondria are aging.” “Circadian disruption is a mitochondrial toxin.” - Key points Mitochondria are sensors, not just ATP producers—your inputs are signals. The gut–EV–mitochondria axis: microbiome metabolites + EV cargo influence mitochondrial function system-wide. Reproductive aging is mitochondrial aging: egg/sperm quality depends on energy, membranes, redox, and QC. ROS isn’t “bad”—it’s normal signaling; damage happens when ROS > antioxidant capacity. The microbiome produces metabolites that shape inflammation, redox control, biogenesis, and mitophagy. Urolithin A = mitophagy / mitochondrial housekeeping signal (microbiome-dependent). Butyrate (SCFA) = gut barrier + inflammation modulation + resilience/biogenesis signaling. EVs are delivery packages that can carry enzymes + regulatory signals; cargo quality matters. Chronic stress/inflammation can shift EV cargo toward broadcasting dysfunction. Senescence loop: mitochondrial dysfunction ↔ ROS ↔ inflammation ↔ senescence (self-amplifying). Practical framing: diet, fiber, polyphenols, sleep timing, light, training = information mitochondria respond to. Longevity strategy = break loops and build resilient systems, not symptom-chasing. - Episode timeline 0:19–2:25 — Why mitochondria are sensors; intro to the gut–EV–mitochondria axis 2:25–4:20 — Reproductive aging as a mitochondrial story; ROS as “controlled fire” 4:20–10:18 — Microbiome metabolites: urolithin A, butyrate, indoles, polyphenol metabolites; “diet = information” 10:18–13:46 — What EVs are; protective vs pro-inflammatory cargo; broadcasting dysfunction 13:46–14:34 — Reproductive aging as a window into systemic aging 14:34–19:32 — Biolite “mitochondria stack” lens: light, MB, hydrogen, DDW, circadian rhythm (systems approach) 19:32–21:28 — Antioxidants misconception; restoring redox intelligence vs blunting adaptation 21:28–24:09 — Big synthesis: breaking loops + “your mitochondria are listening” - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Most “energy” products are just caffeine in disguise — a short-term loan with a brutal crash. In this Deep Dive, we go beyond stimulation and into real cellular energy by decoding a three-compound “energy code” found inside BioElixir MIND: Ergothioneine (EGT), Panax ginseng, and Rhodiola rosea. You’ll learn why EGT is called a “longevity vitamin” (and how it outperforms major antioxidants in lab testing), how the body uses a dedicated transporter (OCTN1) to deliver it into high-risk tissues like the eyes and brain, and why EGT’s stability matters in the real world. Then we shift to Panax ginseng and its surprising links to telomere length and a more youthful NAD⁺/NADH ratio, plus human-reported improvements in sleep, fatigue, cognition, and sexual health. Finally, we break down Rhodiola as a true adaptogen — less “stimulant,” more thermostat — supporting stress resilience, mood, and focus while keeping the cardiovascular system steady. If you’re tired of “wash the windshield” advice, this is the episode that talks about fixing the engine. (Educational content only, not medical advice.) - Articles Discussed in Episode: Ergothioneine: Evaluation of a Novel Antioxidant for Targeting Ocular Oxidative Stress Panax ginseng Meyer supplementation and potential associations with telomere length and NAD+/NADH ratio in middle-aged adults: An exploratory study Phenolic Compounds of Rhodiola rosea L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases - Key Quotes From Dr. Mike: “Most ‘energy’ isn’t energy — it’s borrowing from tomorrow.” “EGT isn’t just strong in a test tube — your body built a VIP entrance specifically to pull it into cells.” “EGT doesn’t just clean up oxidative stress — it helps prevent new damage from forming.” “Ginseng didn’t just change how people felt — it moved biomarkers tied to biological aging.” “Rhodiola isn’t a gas pedal. It’s cruise control.” “Shield, repair, resilience — that’s the real energy code.” - Key points Caffeine ≠ energy: it’s “borrowing energy from tomorrow” with interest. The “Energy Trinity”: EGT (shield) + Panax ginseng (restore) + Rhodiola (resilience). EGT’s standout potency: extreme free-radical scavenging in standardized assays vs common antioxidants. EGT targets the worst offenders: especially hydroxyl radicals and hypochlorous acid. Metal chelation matters: EGT binds free iron/copper to reduce radical formation (prevention, not just cleanup). Bioavailability solved: the body has a dedicated EGT transporter (OCTN1)—a built-in “VIP door.” High-value delivery zones: OCTN1 is highly expressed in the retina/cornea and brain. Real penetration evidence: ocular model shows EGT reaching the back of the eye quickly after topical use. EGT is unusually stable: retains potency under heat/humidity—rare for antioxidants. Ginseng & aging markers: associated with telomere elongation and improved NAD⁺/NADH ratio in humans. Rhodiola = thermostat: improves stress resilience and mental stamina without the jittery stimulant profile. Timing matters: Rhodiola is best earlier in the day to avoid sleep disruption. - Episode timeline 0:19–1:40 – Why modern “energy” is mostly caffeine + maintenance-level advice 1:40–3:45 – The thesis: 3 molecules that unlock cellular energy (and how they map to BioElixir MIND) 4:18–17:35 – Ergothioneine (EGT): potency, what it targets, metal chelation, OCTN1 “VIP transporter,” ocular penetration, and stability 17:38–26:15 – Panax ginseng: telomeres, NAD⁺/NADH ratio, and reported improvements (sleep, fatigue, cognition, sexual health) 26:22–32:20 – Rhodiola rosea: adaptogen definition, stress resilience, neurotransmitter support, calm-focus effect, best timing 32:57–end – The synthesis: EGT = shield, ginseng = restoration, rhodiola = resilience - ⚡ BioElixir MIND: Shield • Restore • Resilience ⚡ BioElixir MIND is built for real cellular energy, not a jittery stimulant spike. Inspired by today’s Deep Dive, it combines ergothioneine (EGT) to help defend high-demand tissues from oxidative stress, Panax ginseng to support the body’s energy and aging architecture (think NAD⁺ balance and cellular renewal), and Rhodiola rosea for calm, steady resilience under stress. BioElixir MIND also incorporates Alpha-GPC + Citicoline, PQQ, Acetyl-L-Carnitine and Shilajit. The result? Smooth cognitive performance without the harsh spikes and crashes. If coffee feels like a loan with interest, MIND is the upgrade: shield the system, restore the engine, and stay sharp without the crash. Clarity isn’t accidental. It’s engineered. Save 15% off your order of BioElixir MIND! Discount code: MIND15 Expires on 3/4, midnight PST *Must use "Single" quantity option; code will not work for 2-, 4- or 10-pack quantity options. Shop BioElixir MIND! - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - St

In this Energy Code Deep Dive, Dr. Mike Belkowski and co-host Don Bailey unpack a 2025 review in Mitochondrion that challenges one of biology’s most entrenched rules: the idea that mitochondrial DNA is inherited only from the mother. For decades, paternal mitochondria were considered disposable “damaged goods” — actively destroyed by the egg through highly conserved cellular cleanup systems. But this episode explores mounting evidence that the rule may be more flexible than we thought, especially under crisis conditions. The hosts break down: why biology usually enforces maternal-only mitochondrial inheritance, how paternal mitochondria are normally eliminated, the controversy over “paternal leakage” and human case reports, why NUMTs (nuclear mitochondrial DNA fossils) created years of scientific confusion, and the breakthrough 2024 fruit fly study that provided functional proof of paternal mitochondrial rescue. Their central takeaway is a powerful new idea: paternal mitochondrial inheritance may not be random leakage at all — it may be a built-in evolutionary fail-safe, a cellular “spare tire” activated only when the mother’s mitochondria fail. This episode reframes biology not as a system of rigid laws, but as a dynamic intelligence built for survival. (Educational content only, not medical advice.) - Article Discussed in Episode: Research progress on paternal mitochondrial inheritance: An overview - Key Quotes From Dr. Mike: “This idea of maternal inheritance has been treated like an absolute law.” “The old rule was simple: dad gives nuclear DNA, mom gives the mitochondria. This paper says the story may be more flexible than that.” “The cell doesn’t reject paternal mitochondria just because they’re from dad — it rejects them because mixing mitochondrial code can create chaos.” “The ‘spare tire’ theory is simple: a damaged backup is still better than no energy at all.” “The cell may be willing to break its own inheritance rules if that’s what it takes to keep ATP flowing and keep life alive.” - Key points The episode challenges a core biology rule: mtDNA may not be strictly maternal in all cases. A 2025 review suggests paternal mtDNA inheritance can occur in crisis conditions. This matters for disease diagnosis, evolution, and metabolic biology. Maternal-only inheritance helps avoid heteroplasmy (conflicting mitochondrial DNA populations). Eggs dominate mtDNA by numbers (huge mtDNA load vs. very few in sperm). Sperm mitochondria are essential for motility but often arrive oxidatively stressed (“damaged goods”). Cells actively destroy paternal mitochondria using robust cleanup pathways (autophagy, ubiquitination, etc.). Rare “paternal leakage” signals were seen for years but often dismissed as anomalies. A 2002 human case showed paternal mtDNA can persist and contribute to disease. The 2018 Luo study reignited the field by reporting biparental inheritance in multiple families. NUMTs complicated the debate because they can mimic mtDNA in standard sequencing. A 2024 fruit fly study provided functional proof of paternal mitochondrial rescue. The key breakthrough: offspring survived despite failed maternal mitochondria, implying functional paternal mitochondria. This supports a “Spare Tire Theory” — paternal mitochondria may act as an emergency backup. The cell may accept heteroplasmy risk to avoid total energy failure. Surviving offspring showed restored mitochondrial function (including Complex I activity). The signaling mechanism is still unknown (how the egg decides to spare paternal mitochondria). This could reshape mitochondrial disease treatment by activating a natural rescue pathway. The idea is to trigger an existing backup system, not invent a new one. Big takeaway: biology may be full of hidden “backup plans” that activate under stress. - Episode timeline 0:19–1:20 — Intro + premise: a “biology law” may be breaking (maternal-only mitochondrial inheritance). 1:20–3:12 — Why it matters: impacts mitochondrial disease, evolution, and metabolic biology. 3:12–5:03 — Standard dogma: mtDNA is maternal to avoid heteroplasmy; egg vs. sperm mtDNA numbers. 5:03–6:30 — Why sperm still carry mitochondria: needed for motility, but often oxidatively damaged. 6:30–8:55 — “Demolition crew” mechanisms: how cells destroy paternal mitochondria (autophagy, ubiquitination, etc.). 8:55–10:31 — Early anomalies: paternal leakage and the 2002 human case of paternal mtDNA persistence. 10:31–13:21 — 2018 Luo study + controversy: biparental inheritance claim vs. NUMT sequencing confounders. 13:21–15:33 — 2024 fruit fly breakthrough: functional proof paternal mitochondria can rescue offspring. 15:33–17:34 — “Spare Tire Theory”: paternal mitochondria as an emergency backup when maternal mitochondria fail. 17:34–18:21 — Open question: how the egg senses failure and pauses paternal mtDNA destruction. 18:21–20:19 — Clinical implications: possible future mitochondrial disease therapies via rescue-pathway activation. 20:19–21:43 — Big-

In this Energy Code Deep Dive, Dr. Mike Belkowski and co-host Don Bailey unpack a striking 2025 paper by Liu and colleagues on gastrointestinal cancers (especially gastric and colorectal tumors) and why we may be looking in the wrong place for answers. Instead of focusing only on DNA mutations, this episode explores the mitochondria as the cell’s decision-makers; the organelles that help determine whether a cell grows, rests, or dies. The hosts break down the paper’s framework of mitochondrial quality control (MQC) into three core pillars: biogenesis (make), dynamics (shape), and mitophagy(break/recycle). They explain how tumors hijack these systems to fuel growth, metastasis, and drug resistance — and how therapies may work by disrupting the cancer cell’s energy code, not just damaging DNA. The conversation also covers PGC-1α, fission/fusion proteins, mitophagy under hypoxia, chemo resistance, and a fascinating (and very weird) malaria-related finding that reinforces the core concept. The big takeaway: cancer may be less about a broken blueprint and more about a corrupted energy system. (Educational content only, not medical advice.) - Article Discussed in Episode: The role of mitochondrial biogenesis, mitochondrial dynamics and mitophagy in gastrointestinal tumors - Key Quotes From Dr. Mike: “There is no one-size-fits-all energy code.” “Cancer isn’t just a genetic accident, it’s a fundamental corruption of how the cell handles energy.” “The shape of the mitochondria literally determines how well chemotherapy works.” “Cancer operates in a Goldilocks zone.” “Proton beam therapy… also works by hacking the energy code.” - Key points GI cancers remain a massive global burden The episode opens with sobering numbers: millions of new GI tumor cases and deaths annually. Focus is specifically on gastric and colorectal cancers. The paper shifts focus from DNA to mitochondria Modern oncology often centers on mutations. This review argues mitochondria are not just “batteries” — they are decision-makers controlling cell fate. Cancer is framed as a corruption of the “energy code” The hosts describe tumors as hijacking mitochondrial decision-making. Cancer rewrites the systems that regulate growth, dormancy, and apoptosis. Mitochondrial Quality Control (MQC) is the core framework The paper’s model has three pillars: Biogenesis (making mitochondria) Dynamics (shaping mitochondria via fission/fusion) Mitophagy (recycling damaged mitochondria) The hosts summarize this as: “make, shape, and break.” Pillar 1: Biogenesis fuels tumor growth Tumors need energy to expand, so they ramp up mitochondrial production. PGC-1α is presented as the key “foreman” regulating this process. Cancer operates in a biogenesis Goldilocks zone Some biogenesis is necessary for tumor growth. But too much PGC-1α can push cells into apoptosis (cell death), making it a fragile balance. Excess biogenesis can become toxic to cancer Overproduction of mitochondria can trigger death pathways (via BAX/Bak-type mitochondrial apoptosis signaling, as described in the transcript). This creates a therapeutic opportunity: push tumor energy systems beyond their tolerance. Tumors actively silence genes that would normalize metabolism The episode describes a gastric cancer example where a gene is silenced/methylated to preserve the tumor’s metabolic advantage (including the Warburg effect dynamics). Proton beam therapy may work partly by disrupting mitochondrial balance The hosts note a non-obvious mechanism: Beyond DNA damage, proton therapy may force excess mitochondrial biogenesis and push tumors into collapse. Pillar 2: Mitochondrial dynamics = shape-shifting for survival Mitochondria constantly undergo: Fission (splitting) Fusion (merging) This is described with a “lava lamp” analogy. Fission supports metastasis Fragmented mitochondria are easier to move within the cell. Cancer uses this to bring energy to the “leading edge” during invasion and spread. Fusion/fission proteins are strategic levers The episode highlights: DRP1 (fission) MFN1, MFN2, OPA1 (fusion) Aggressive tumors exploit these pathways to support mobility and growth. Chemo resistance is partly an energy-grid strategy In Adriamycin-resistant cells, tumors increase fission and reduce fusion. By breaking mitochondrial networks into “islands,” they quarantine damage and survive drug stress. Mitochondrial shape influences chemotherapy effectiveness The episode emphasizes that mitochondrial structure is not cosmetic — it changes treatment response. The “energy grid” layout can determine whether toxicity spreads or is contained. Pillar 3: Mitophagy = recycling damaged engines Mitophagy is a mitochondria-specific form of autophagy. In healthy cells, it’s protective quality control (e.g., PINK1/Parkin pathway). Tumors weaponize mitophagy under stress In nutrient-poor or hypoxic tumor cores, cancer ramps up mitophagy to recycle parts and survive. The recycling center becomes a survival grocery store. Hypoxia

In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey unpack a powerful new model of aging: it’s not just “wear and tear” — it’s a communication breakdown between two core systems in the cell: telomeres (the clock) and mitochondria (the engine). Based on a recent review in the International Journal of Molecular Sciences, this episode explores how these two longevity pillars are deeply linked through oxidative stress, telomerase (TERT), and the p53 pathway. The hosts explain how damaged telomeres can shut down mitochondrial biogenesis, how dysfunctional mitochondria accelerate telomere erosion, and why this feedback loop drives cellular senescence, immune aging, and tissue decline. They also dive into the “TERT commuting” phenomenon (telomerase moving into mitochondria), the role of ROS in damaging guanine-rich telomeres, the rise of “zombie cells,” extracellular citrate as a possible future aging biomarker, and the biggest twist of all: why sperm cells seem to bend the rules of aging — and how cancer hijacks the same system. This is a big-picture episode about aging, metabolism, and longevity strategy: if you want to protect your DNA, you have to protect your mitochondria. (Educational content only, not medical advice.) - Article Discussed in Episode: Exploring the Link Between Telomeres and Mitochondria: Mechanisms and Implications in Different Cell Types - Key Quotes From Dr. Mike: “Aging isn’t just parts breaking down in isolation. It’s a communication breakdown.” “The clock breaks the engine, and the engine breaks the clock.” “TERT isn’t just for making you live longer by lengthening telomeres… it’s trying to keep the power on too.” “Biology prioritizes safety over repair.” “If you wanna protect your DNA, your telomeres — you have to protect your mitochondria.” - Key points Aging is framed as a communication breakdown, not just mechanical wear The episode challenges the “slow breakdown” model of aging. Instead, aging is described as a cellular civil war between telomeres and mitochondria. The paper links two traditionally separate longevity domains Telomere biology and mitochondrial biology are often studied independently. This review argues they are part of the same core aging system. Telomeres are the cell’s “clock” Telomeres protect chromosome ends like shoelace tips. They shorten with cell division (Hayflick limit), eventually triggering senescence. Mitochondria are the cell’s “engine” They generate ATP but also produce ROS (reactive oxygen species) as metabolic exhaust. Small ROS = signaling; too much ROS = oxidative damage. TERT isn’t only nuclear — it also goes into mitochondria A major insight from the episode: ~10–20% of TERT can localize to mitochondria. Under mild stress, the cell sends TERT to mitochondria as a protective shield against ROS damage. The “axis of aging”: short telomeres trigger a p53 shutdown cascade Critically short/damaged telomeres activate DNA damage response (DDR). This activates p53, which prioritizes safety (anti-cancer control) over repair. p53 suppresses mitochondrial renewal p53 represses PGC-1α / PGC-1β (mitochondrial biogenesis regulators). It also suppresses SIRT1, worsening metabolic decline. The result: fewer new mitochondria, failing old mitochondria, and cellular senescence. Mitochondria can “break the clock” too Dysfunctional mitochondria leak excess ROS. ROS preferentially damages guanine-rich telomeric DNA, accelerating telomere shortening. Why telomeres are especially vulnerable to oxidative stress Telomeres are rich in guanine (G), which has low redox potential (“rusts easily”). ROS oxidizes guanine into 8-oxo-dG, impairing replication and telomere integrity. This creates a vicious cycle (death spiral) Mitochondrial dysfunction → ROS → telomere damage → p53 activation → mitochondrial shutdown. The cell becomes trapped in senescence. Immune aging is a real-world example of this loop T cells need massive ATP to proliferate during infection. In older adults, shortened telomeres and p53 signaling impair mitochondrial function. This contributes to immunosenescence (weaker immune response with age). Skin aging also reflects the telomere-mitochondria link Fibroblasts under UV/oxidative stress show faster telomere shortening. Even without rapid division, poor metabolism can age tissue faster. PBM/red light therapy is framed as a “genome protection” strategy The hosts connect photobiomodulation (PBM) to improved mitochondrial efficiency and lower ROS. Their argument: better mitochondrial function may help protect telomeres indirectly by reducing oxidative stress. Senescent cells undergo metabolic reprogramming They shift from oxidative phosphorylation (OXPHOS) to glycolysis. This is less efficient and leads to metabolite buildup, especially citrate. Extracellular citrate may be a future aging biomarker Senescent cells can dump citrate outside the cell (“extracellular senescence metabolism”). The episode suggests this “cellular trash” could become a real

In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey challenge one of the biggest assumptions in reproductive health: that age-related infertility is only about “running out of time.” Instead, they explore a bold idea from a 2024 case series—what if the deeper issue is running out of cellular energy? This episode unpacks a study on multi-wavelength red and near-infrared photobiomodulation (PBM) used in women ages 40–43 with difficult fertility histories, including failed IVF cycles and miscarriages. The hosts explain why the egg cell is the most mitochondria-dense cell in the body, how mitochondrial decline affects egg quality and chromosomal accuracy, and how PBM may help by boosting ATP production, improving blood flow, reducing inflammation, and supporting the reproductive environment. They also break down the surprisingly systemic treatment protocol (abdomen, lower back, neck, lymph, gut), why multi-wavelength light matters for tissue depth, and the three case outcomes that make this paper so compelling: 3 women treated, 3 live births. The big takeaway: fertility may not just be a hormonal “software” issue, it may be a mitochondrial hardware and energy issue. (Educational content only, not medical advice.) - Article Discussed in Episode: The Efficacy of Multiwavelength Red and Near-Infrared Transdermal Photobiomodulation Light Therapy in Enhancing Female Fertility Outcomes and Improving Reproductive Health: A Prospective Case Series with 9-Month Follow-Up - Key Quotes From Dr. Mike: “What if the problem isn’t that women are running out of time? What if the problem is simply that they’re running out of energy?” “If you could fix that energy problem, you might just be able to rewrite the entire code on fertility.” “The human oocyte contains more mitochondria than any other cell in the body.” “You are literally recharging the biological battery of the egg.” “If you only used red light, you’d be treating the skin, but totally missing the engine room.” “Perhaps the future of fertility… is simply about turning on the light.” - Key points The episode reframes age-related infertility as an energy problem Instead of only “biological clock” decline, the hosts argue fertility may be limited by mitochondrial energy capacity. The paper focuses on a high-risk fertility demographic Women ages 40–43, often labeled “poor prognosis,” with failed IVF and miscarriage histories. The headline result is striking In a small case series, the study reports 3 women treated, 3 live births (100%). The hosts correctly note this is a very small sample size—but still a strong signal. Egg cells are mitochondria-heavy Oocytes contain far more mitochondria than most other cell types because they require enormous energy for meiosis and chromosomal segregation. Mitochondrial decline may drive poor egg quality with age As mitochondrial function declines, ATP output drops and chromosomal errors increase. This contributes to aneuploidy, failed IVF, and miscarriage risk. PBM is presented as a mitochondrial “fuel injection” Red and near-infrared light stimulate cytochrome c oxidase, supporting ATP production and cellular energy. The treatment target is not just the ovaries The protocol treated: Lower abdomen (ovaries/uterus) Lower back/sacrum (nerve roots) Neck/cervical region + clavicular lymph nodes (brainstem/vagus influence) Gut/navel region (microbiome + estrogen metabolism) The “proximal priority theory” is a key concept Treating the neck may support the brain-hormone axis and vagus nerve, helping shift the body from stress mode to reproductive mode. The protocol used multi-wavelength PBM 660 nm red + near-infrared wavelengths (810/850/940 nm) Red supports superficial tissues; near-infrared penetrates deeper to reach pelvic structures. Case 1: recurrent miscarriage history → euploid embryos + live birth A 41-year-old with miscarriages/molar pregnancy produced multiple blastocysts, including two euploid embryos, and had a live birth at 42. Case 2: 4 failed IVF cycles → success after higher-frequency PBM PBM every 2–3 days during stimulation; a day-3 fresh transfer succeeded, suggesting improved uterine receptivity. Case 3: failed embryo transfer → natural conception after PBM After a difficult IVF course and failed transfer, she did a PBM protocol for natural conception and conceived naturally. Pregnancy safety was addressed cautiously During early pregnancy support, the protocol was modified: No abdominal treatment Focus on cervical spine, lymph nodes, and feet The hosts discuss penetration depth and systemic support rather than direct fetal exposure. The larger thesis: fertility treatment often focuses on “software” Hormones/manipulation = software Mitochondria/blood flow/cellular energy = hardware PBM is presented as a hardware-first strategy. - Episode timeline 0:19–1:14 — Intro and paradigm shift setup The hosts challenge the “biological clock” narrative and introduce the idea that infertility may be more about energy than

Chronic pain affects an enormous portion of the population and for decades, the default answers have been drugs, sedation, or invasive procedures. In this Energy Code Deep Dive, Dr. Mike Belkowski and Don Bailey unpack a 2026 systematic review (Ferreira et al.) that analyzed 14 randomized controlled trials on photobiomodulation (PBM) for chronic pain conditions, including fibromyalgia, neuropathy, TMJ/TMD, and post-COVID pain. They break down the “energy code” behind PBM: how red and near-infrared light can stimulate mitochondria to produce more ATP, lower inflammatory cytokines (like IL-1β, IL-6, and TNF-α), and modulate pain signaling in both peripheral nerves and the central nervous system. The episode also covers why PBM is not “just shining a flashlight,” why dosing and wavelength precision matter, and why this field may represent a shift from the chemical age of medicineto the energy age. Most importantly, they discuss the clinical implications: meaningful symptom relief, improved function and quality of life, and a remarkably strong safety profile—with 13 of 14 trials reporting zero adverse events. (Educational content only, not medical advice.) - Article Discussed in Episode: Photobiomodulation in chronic pain: a systematic review of randomized clinical trials - Key Quotes From Dr. Mike: “What if the answer (to chronic pain) wasn’t chemical at all? What if the answer was actually energetic?” “You’re making the world less hostile to their bodies.” (re: fibromyalgia pain threshold) “We’re talking about repairing the wiring, not just muting the signal.” “PBM doesn’t just numb the pain… it is returning the tissue to a functional state.” “We are moving from the chemical age to the energy age.” - Key points Chronic pain is a massive global problem The episode frames chronic pain as a major public health crisis, affecting a huge percentage of adults worldwide. PBM is not “flashlight therapy” This is a precise medical/biological intervention using specific wavelengths and dosing parameters—not generic red light. The episode centers on a 2026 systematic review Ferreira et al. analyzed 14 randomized controlled trials (2015–2025), making this one of the strongest summaries of recent PBM pain research. PBM works through a 3-pronged mechanism Mitochondrial boost (more ATP / “recharging the battery”) Inflammation reduction (lower IL-1β, IL-6, TNF-α, prostaglandins) Neural modulation (reduced pain fiber excitability + neurotransmitter shifts) Wavelength and power density are everything The biological “key” usually falls in the 660–905 nm range, with correct irradiance needed to trigger a mitochondrial response. Fibromyalgia results were especially encouraging The review highlighted rigorous trials (including triple-blinded designs) showing reduced tender points, lower pain, and improved pain threshold. Whole-body PBM may improve quality of life In addition to symptom reduction, some studies showed improvements in health-related quality of life, which matters deeply in chronic pain. Neuropathy outcomes were clinically meaningful Chemotherapy-induced neuropathy: notable response rates and reduced neuropathy scores Diabetic neuropathy: significant pain reductions using LED-based protocols PBM may help post-COVID pain syndromes The review included data on post-COVID orofacial pain and tension headaches, with reductions in pain scores and improvements in sleep/enjoyment of life. TMJ/TMD results suggest PBM is best as part of a plan PBM helped in some studies, but manual therapy sometimes performed similarly—supporting a multi-modalapproach. Safety is one of PBM’s strongest advantages 13 out of 14 trials reported zero adverse events; the only noted effects were mild/transient warmth or tingling. The big limitation: protocol heterogeneity Different wavelengths, doses, and treatment durations make standardization difficult—this is the “wild west” problem. PBM may restore function, not just reduce pain The review found improvements in walking, working ability, sleep, and daily functioning—not just lower pain scores. The larger theme: a shift to energy medicine The episode closes on the idea that medicine may be moving from a “chemical age” to an “energy age.” - Episode timeline 0:19–1:28 — Intro: chronic pain as a global crisis Don and Dr. Mike frame the scale of chronic pain and introduce the central question: can light treat pain? 1:28–2:40 — The review they’re unpacking (Ferreira, 2026) Overview of the systematic review in Frontiers in Integrative Neuroscience and its 14 RCTs. 2:40–3:34 — Skeptic question: “Is this just a flashlight?” They address the common misconception and define PBM as a real scientific modality. 3:34–6:59 — How PBM works: the 3-pronged mechanism Mitochondrial ATP boost Inflammation reduction Neural modulation Includes why 660–905 nm and irradiance matter. 7:00–9:16 — Fibromyalgia: one of the toughest pain conditions Discussion of key fibromyalgia studies, including a triple-blinded RCT and whole-bo

What if your thyroid gland isn’t just a chemical factory—but a light-sensing organ with the hardware to “see”? In this Energy Code Deep Dive, we unpack a jaw-dropping paper: “Wearable Photobiomodulation Halts Thyroid Cancer Growth by Leveraging Thyroid Photosensitivity.” The study suggests papillary thyroid carcinoma cells express opsins(photoreceptor proteins like those in the retina)—specifically a short-wavelength opsin tuned for blue light. Researchers ran a “wavelength war” (red vs green vs blue) and found 465 nm blue light uniquely halted cancer growth, first by cell-cycle arrest and then—inside living animals—by triggering apoptosis (cell self-destruction). Even wilder: they engineered a battery-free, NFC-powered wearable that delivered a precise dose over weeks, suppressing tumors while leaving thyroid hormone function intact. This episode reframes light as an instruction set—and asks the bigger question: are we “light malnourished” in a world spent indoors? (Educational content only, not medical advice.) - Article Discussed in Episode: Wearable photobiomodulation halts thyroid cancer growth by leveraging thyroid photosensitivity - Key Quotes From Dr. Mike: “They discovered the thyroid itself is a non-visual photoreceptive organ.” “The thyroid has a built-in antenna for blue light.” “We’ve been ignoring the optical anatomy of the human body.” “Light is an instruction set for the world inside of us.” “Maybe our internal organs are literally starving for the right kind of light.” - Key points The thyroid may be photoreceptive: thyroid cancer cells were found to contain opsins, the same class of light-sensing proteins used for vision. OPN1SW shows up in thyroid cancer: a short-wavelength opsin suggests the tissue is tuned to blue lightsignaling. PBMT ≠ PDT: photodynamic therapy requires injected dyes; photobiomodulation uses intrinsic biology—no photosensitizer needed. A “wavelength war” identified the winner: red (650 nm) and green (520 nm) did nothing; blue (465 nm) significantly inhibited proliferation. Mechanism in vitro: cell-cycle arrest: blue light trapped cells in G0/G1, increasing P21 (brake) and decreasing CDK4 (gas pedal). Dose matters: effects were dose-dependent, with an optimal 24-hour cycle delivering 172.8 J—“light is a drug.” Blue light penetration challenge addressed: in 3D tumor spheroids, the blue light still reduced tumor volume over 7 days. Real-world delivery required engineering: a thin wireless wearable patch powered by NFC (tap-to-pay tech) delivered therapy without a battery. In vivo effect: apoptosis: in mice, tumors didn’t just pause—they underwent programmed cell death. Why dish vs body differs: possible “endogenous photosensitizers” generated by metabolism and/or immune involvement in living systems. Safety profile stood out: thyroid hormones (T3/T4) remained stable; no weight loss; no liver/kidney toxicity markers. Paradigm shift: suggests a future of organ-preserving, non-invasive metabolic/energetic medicine—and expands the idea that organs may be energy “antennas.” - Episode timeline 0:19–1:16 — Hook: organs that can “see” The thyroid as a light-sensing organ; intro to the study and why it matters. 1:16–3:16 — Thyroid cancer + why current treatment is brutal Papillary thyroid carcinoma prevalence; “good cancer” myth; thyroidectomy/radioiodine tradeoff and lifelong hormone dependence. 3:16–4:08 — PDT vs PBMT Why this isn’t lasers or dye-based photodynamic therapy; PBMT uses intrinsic cellular “hardware.” 4:08–5:29 — The smoking gun: opsins in thyroid cancer Non-visual photoreception; opsins in thyroid tissue; OPN1SW implies blue-light sensitivity. 5:29–7:33 — The ‘wavelength war’ + mechanism 650 red / 520 green / 465 blue; blue inhibits proliferation via G0/G1 arrest; P21 up, CDK4 down. 7:33–8:23 — Dose precision: Arndt–Schulz law Light as a dose-dependent medicine; optimal 172.8 J over a 24-hour cycle. 8:23–9:17 — The penetration skeptic test 3D tumor spheroids; tumor volume shrinks over 7 days—blue can work in 3D at correct intensity. 9:17–10:27 — Wearable engineering solution Battery-free, flexible, wireless blue LED patch; NFC-powered; biocompatible coating. 10:27–12:05 — In vivo results: from “pause” to “kill” 21-day mouse study: tumors suppressed; apoptosis in living system; endogenous photosensitizers and/or immune assist hypothesis. 12:05–13:22 — The safety miracle No collateral damage; T3/T4 stable; no systemic toxicity markers. 13:22–14:28 — Big implications Non-invasive organ-preserving cancer therapy; opens question of other light-sensitive organs. 14:28–15:24 — Recap: 3 key takeaways Body as light receiver; specificity of 465 nm + dose; wearables make it practical now. 15:24–16:26 — Final thought: “light malnourished” If thyroid expects solar blue-light signals, what does indoor life do to biology? - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glas

Most people think mitochondria are just tiny “powerhouses.” In this deep dive, Dr. Mike Belkowski breaks that outdated meme wide open by portraying mitochondria as a dynamic, shape-shifting power grid that talks to your nucleus, runs cellular quality control, and can even transfer between cells like an organelle transplant. Using a major 2025 review on mitochondrial diseases and therapeutic advances as the roadmap, we unpack the real mechanics of energy production (the “hydroelectric dam” of oxidative phosphorylation), why mitochondrial DNA is uniquely vulnerable, how dysfunctional mitochondria can trigger chronic inflammation, and why tools like exercise and light aren’t wellness trends — they’re direct inputs into your energy hardware. Then we go full sci-fi (but real): gene therapy, “three-parent babies,” precision editing of mitochondrial mutations, and the emerging possibility of mitochondrial transfer as a future regenerative therapy. (Educational content only, not medical advice.) - Article Discussed in Episode: Mitochondrial diseases: from molecular mechanisms to therapeutic advances - Key Quotes From Dr. Mike: “That powerhouse meme is so outdated—it’s like calling a supercomputer a calculator.” “Mitochondria are a constantly moving, dynamic network… like a mobile power grid.” “You breathe so oxygen can be the trash can for electrons at the end of the line.” “Fusion is a rescue mission. Fission is quarantine.” “You can swallow all the anti-inflammatory supplements you want—but if the pipe is still burst, you’re just mopping the floor.” - Key points Mitochondria are dynamic networks, not static beans—they fuse, split, move, and deliver energy where it’s needed. They’re “alien” in origin: mitochondria evolved from bacteria that formed a symbiotic relationship with early cells. You run on two genetic systems: nuclear DNA + mitochondrial DNA (mtDNA), and mtDNA is far more exposed to damage. mtDNA is vulnerable by design—it lacks histone “armor” and sits next to the ROS-producing “furnace.” Mitochondria require constant nuclear support: mtDNA encodes a tiny fraction of needed proteins; most are built in the nucleus and imported via the TOM/TIM “mailroom.” Mitochondria talk back via mitochondrial-derived peptides (ex: MOTS-c) that can influence gene expression. Energy production is mechanical: electron transport pumps protons to build a gradient that drives ATP synthaselike a turbine. Supercomplexes improve efficiency and reduce “dropped electrons” (free radicals). Quality control is built-in: fusion rescues; fission isolates damage; PINK1/Parkin flags failing mitochondria for mitophagy; MDVs prune small defects. Mitochondria can trigger inflammation: severe damage can spill mtDNA and activate immune alarm pathways—fueling chronic “inflammaging.” Disease depends on heteroplasmy: you can carry mutations and remain healthy until a threshold of “bad copies” is reached in high-energy tissues. Light is a mitochondrial input: red/NIR can support energy machinery, while high-energy blue light can be a stressor—especially in vulnerable tissues. Repair is becoming real: bypass drugs, peptides that stabilize membranes, lifestyle upgrades (exercise → PGC-1α), and frontier therapies like gene transfer and mtDNA editing. - Episode timeline 0:00–0:38 — Opening + mission The Energy Code premise: decode mitochondria to build “limitless vitality.” 0:38–2:20 — The myth: mitochondria aren’t just powerhouses Why the “kidney bean” model is obsolete—and what the 2025 review changes. 2:20–4:47 — Origin story: the ‘alien’ inside you Endosymbiosis + why mitochondria have their own DNA. 5:00–7:18 — mtDNA: the fragile code behind aging No histone protection, proximity to ROS, high mutation rate, maternal inheritance. 7:32–9:11 — Nuclear ↔ mitochondrial logistics Why mitochondria need 1000+ proteins; TOM/TIM import system and “zip codes.” 9:22–10:21 — Messages from the power plant Mitochondrial-derived peptides (ex: MOTS-c) as whole-body metabolic regulators. 10:25–14:16 — The operating system: OXPHOS explained Hydroelectric dam analogy, ETC complexes, ATP synthase turbine, oxygen as terminal acceptor; supercomplexes reduce free radicals. 14:27–17:36 — Quality control: fusion, fission, mitophagy, MDVs Rescue vs quarantine; PINK1/Parkin “condemned sign”; targeted pruning. 17:48–18:58 — The sci-fi reality: mitochondria transfer between cells Tunneling nanotubes, rescue donations, and garbage handoffs. 19:00–24:35 — Mitochondrial diseases + heteroplasmy threshold Why symptoms hit high-energy tissues first; examples: LHON, MELAS, Barth syndrome; cardiolipin as “glue” for supercomplexes. 24:41–27:19 — ROS + the inflammation connection ROS as signaling vs chronic overload; mtDNA leakage, immune alarms, inflammaging. 27:33–33:40 — Hacking the code: therapies now + next Bypass strategies (idebenone), structural stabilizers (elamipretide), exercise → PGC-1α (biogenesis + mitophagy), allotopic expression, mitochondrial replacement therapy, mi

Tooth sensitivity isn’t a minor annoyance, it’s that electric jolt from a popsicle or coffee that can ruin your day. For decades, the standard fix has been chemical pastes and fluoride varnishes that temporarily seal exposed dentin. But this deep dive breaks down a pilot study asking a different question: what if the best solution isn’t something you smear on your teeth… but something you shine on them? We unpack a home-use photobiomodulation (PBM) toothbrush protocol using 660nm red light, designed to stimulate cellular energy and healing pathways. Instead of only “boarding up the broken window” (sealing tubules from the outside), PBM may trigger secondary dentin formation that helps the tooth rebuild and close tubules from the inside out, while also calming nerve signaling, boosting local endorphins, and reducing gum inflammation. The headline result: at one month, home-use PBM delivered pain relief comparable to clinic fluoride varnish, and the combination approach produced the biggest win—taking severe sensitivity down to nearly zero. (Educational content only, not medical advice.) - Article Discussed in Episode: The Protective Effect of Ellagic Acid and Its Metabolites Against Organ Injuries: A Mitochondrial Perspective - Key Quotes From Dr. Mike: “The solution might not be something you smear on your teeth… but something you shine on them.” “660 nanometers (red light) is the sweet spot for healing.” “It’s not masking the pain — it’s inducing repair...The tooth is actually healing itself… closing its own doors.” “The light is telling the house to rebuild the wall from the inside.” “A clinical-grade relief without the clinic.” - Key points Tooth sensitivity often comes from gum recession exposing dentin, not enamel. Dentin contains dentinal tubules (tiny channels) that connect to the tooth’s nerve-rich pulp. Cold/heat triggers fluid movement in tubules → instant nerve activation (“live wire” pain). Standard treatments (potassium nitrate toothpaste, fluoride varnish) aim to block tubules chemically—often temporarily. PBM is different: dose + wavelength matter (“biology is a lock; you need the right key”). This study used 660nm red light—chosen for tissue penetration and mitochondrial stimulation (ATP support). PBM’s proposed triple mechanism: Secondary dentin production (structural repair from inside out) Neural modulation + endorphins (calmer pain transmission) Reduced gum inflammation (healthier oral environment) Study design: 30 patients, split into 3 groups: varnish-only, PBM toothbrush-only, and combination. Results (VAS pain scores) after ~1 month: Varnish: ~8.2 → 2.1 PBM toothbrush: ~7.9 → 2.4 Combo: ~8.3 → 0.8 Unexpected added benefit: PBM group saw a plaque index reduction (possible bacteriostatic effects + less inflamed pockets). Safety: no side effects reported in the study. Convenience matters: PBM fits into brushing — zero behavior change vs multiple clinic appointments. Bigger implication: moving from “maintenance” to regeneration in everyday oral care. - Episode timeline 0:19 – 1:20 — Hook: the “electric jolt” of sensitivity; chemicals vs the idea of light 1:20 – 2:34 — Skepticism + framing: PBM toothbrush study; 660nm parameters; home-counter therapy 2:40 – 4:36 — The anatomy of “ouch”: gum recession → exposed dentin → tubules → fluid shift → nerve zap; varnish as temporary seal 4:43 – 5:53 — Study design: 30 patients, 3 groups (varnish / PBM brush / combo) and protocols 5:58 – 6:52 — Why wavelength matters: “lock and key,” 660nm as therapeutic target (ATP/mitochondria) 6:53 – 8:15 — Mechanisms: secondary dentin, neural modulation + endorphins, reduced inflammation (repair vs masking) 8:22 – 10:41 — Results: VAS tests (probe + air blast); varnish ≈ PBM; combo best (down to 0.8); synergy explanation 10:44 – 11:45 — Plaque finding: plaque index improved in PBM group; ecosystem/inflammation angle 11:50 – 13:06 — Safety + convenience: no side effects; “massive hassle” vs “just brush” 13:17 – 14:41 — Autonomy + regeneration framing: toothbrush as “medical device”; PBM beyond sensitivity 14:56 – 16:14 — Closing philosophy: decline isn’t inevitable; “sometimes all it takes is a little bit of light”; broader body implications - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive, we go back to the foundation: why you feel energized and resilient—or wrecked and inflamed—often comes down to mitochondrial function. Using a comprehensive review on ellagic acid, we unpack the mitochondria’s central dilemma: they’re power plants that produce ATP… but they also produce reactive oxygen species (ROS)—their own “exhaust.” When ROS outpaces your internal cleanup systems, mitochondria enter a vicious cycle (“ROS-induced ROS release”), fragment, lose membrane potential, and can trigger apoptosis via cytochrome c—an early domino in organ stress and failure. Then comes the twist: ellagic acid from pomegranates, berries, and walnuts is poorly bioavailable—until your gut microbiome upgrades it into urolithins (A–D). Those urolithins act as both antioxidants and signaling molecules that flip key defense and longevity switches (NRF2, SIRT1/SIRT3), while activating mitophagy—the cell’s “quality control” that removes broken mitochondria and helps rebuild healthy ones. Finally, we go organ-by-organ through what the review suggests in models: mitochondrial protection in the liver(acetaminophen, methotrexate), kidneys (gentamicin), heart (doxorubicin, diabetic cardiomyopathy), and brain(Parkinson’s rotenone model, Alzheimer’s clearance systems)—and end with a sobering insight: antibiotics may both damage mitochondria and wipe out the very bacteria you need to make urolithins. (Educational content only, not medical advice.) - Article Discussed in Episode: The Protective Effect of Ellagic Acid and Its Metabolites Against Organ Injuries: A Mitochondrial Perspective - Key Quotes From Dr. Mike: “When you peel back all the layers of health and longevity… you end up at the mitochondria.” “Gut health is mitochondrial health.” “The mitochondria basically pull the pin on a grenade and tell the cell to self-destruct.” “You aren’t the one processing (ellagic acid [Urolithin A])—your bacteria are.” “Mitophagy is a quality-control team—it takes out the trash.” “By wiping out gut diversity, we might be locking ourselves out of our own energy code.” - Key points The “energy code” starts at the mitochondria: not just energy production, but cell survival decisions. Mitochondria create ATP via the electron transport chain, but it “leaks,” generating ROS/free radicals. When ROS overwhelms cleanup capacity, a vicious cycle begins: ROS-induced ROS release. Damaged mitochondria swell, fragment, lose membrane potential, and can release cytochrome c → apoptosis. Ellagic acid is found in pomegranates, berries, walnuts; but has poor bioavailability on its own. The microbiome is the real refinery: gut bacteria convert ellagic acid into urolithins (A–D) that are highly bioavailable. The episode’s core reframing: “You aren’t what you eat—you’re what your bacteria do with what you eat.” Urolithins do more than “antioxidant mop-up”: they act as signaling molecules that activate NRF2 (endogenous defenses). Urolithins also activate SIRT1/SIRT3, which are longevity-linked efficiency and stress-resilience pathways. The star mechanism: mitophagy (removing broken mitochondria) + mitochondrial renewal/biogenesis (“fleet maintenance”). The review’s models suggest protective effects across organs under chemical/drug stress (liver, kidney, heart, brain). Antibiotics create a double hit: mitochondrial stress + microbiome depletion → locking you out of the urolithin pathway. Practical takeaway: mitochondrial health is a systems problem—diet + microbiome + stress/toxin exposure. - Episode timeline 0:00 – 0:33 — Framing: ditch fads; go microscopic; why you feel “conquer the world” vs “hit by a truck” 0:33 – 1:33 — Mitochondria as “masters of destiny”; intro to ellagic acid as a potential guardian 1:46 – 4:12 — The problem: mitochondrial “exhaust” (ROS), leakage, ROS-induced ROS release, swelling/fragmentation, membrane potential collapse, cytochrome c → apoptosis 4:19 – 5:03 — Where ellagic acid is found + the catch: hydrophobic → poor bioavailability 5:08 – 6:13 — The twist: microbiome as chemical refinery → urolithins A–D; “you are what your bacteria do” 6:19 – 8:49 — What urolithins do: antioxidant + signaling (NRF2), sirtuins (SIRT1/SIRT3), mitophagy + renewal 9:00 – 10:07 — Liver protection models: acetaminophen/Tylenol; methotrexate; preserving ATP and blocking cytochrome c leak 10:09 – 10:46 — Kidney protection model: gentamicin nephrotoxicity; maintaining membrane potential 10:49 – 12:08 — Heart protection: doxorubicin “red devil,” mitochondrial fission/fragmentation; diabetic cardiomyopathy via NRF2 12:14 – 13:33 — Brain: crosses BBB; Parkinson’s rotenone model (complex I); Alzheimer’s waste clearance/lysosomes 13:47 – 14:33 — Zoom out: “universal body armor” + microbiome partnership; feeding the “garden” (prebiotics/fiber) 14:45 – 15:41 — Double-edged sword of antibiotics: mitochondrial damage + microbiome wipeout; closing takeaway 15:43 – 15:59 — Wrap + call to action: “everything you do is a signal — send the

In this The Energy Code Deep Dives episode, we challenge the standard “cancer is a genetic lottery” narrative and explore a different frame: cancer as a metabolic disease rooted in mitochondrial respiratory failure. Using a 2025 mini-review from Journal of Bioenergetics and Biomembranes led by Thomas Seyfried, we revisit Otto Warburg’s original two-step hypothesis: damaged respiration (OXPHOS) → compensation via fermentation (even in oxygen). Then we unpack why a mid-century “oxygen consumption = healthy mitochondria” assumption derailed the field, and how modern data reframes that as a measurement trap. From there, the episode explains cancer’s dual-fuel reality (glucose + glutamine), why growth requires rerouting carbon “building blocks,” and the “smoking gun” nuclear transfer experiments that suggest the core defect is mitochondrial/cytoplasmic, with DNA mutations as downstream damage. Finally, we get practical with Seyfried’s press-pulse approach: a sustained “press” on glucose via ketogenic metabolic therapy, and a rhythmic “pulse” targeting glutamine—measured using the glucose-ketone index (GKI)—all aiming to starve the tumor while fueling healthy cells. (Educational content only, not medical advice.) - Article Discussed in Episode: The Warburg hypothesis and the emergence of the mitochondrial metabolic theory of cancer - Key Quotes From Dr. Mike: “If we treat cancer as a metabolic disease… it changes everything.” “Oxygen consumption is not a reliable marker for energy production.” “Cancer is a dual-fuel disease.” “You’re starving the enemy while fueling your own army.” “Energy is what creates order… it’s what maintains your cellular identity.” - Key points The episode’s core premise: cancer may be better understood as a metabolic/energy disease than a purely genetic one. Warburg’s two-step model: respiratory damage → persistent fermentation (aerobic fermentation) for survival. Why the field pivoted: mid-century findings that some cancer cells consumed lots of oxygen led to the assumption mitochondria must be fine. The “logic trap”: oxygen consumption ≠ efficient ATP production (a “revving engine in neutral”). When mitochondria are “uncoupled,” oxygen use can rise while ATP output is impaired, producing more ROS “exhaust.” Cancer’s “missing math”: glucose fermentation alone can’t explain rapid growth → second backup source: glutamine-driven mitochondrial substrate-level phosphorylation (MSLP). Cancer becomes a dual-fuel fermentation system, producing “toxic exhaust” (lactate + succinate). Growth logic: PKM2 creates a metabolic bottleneck so carbon building blocks accumulate for biomass (membranes/DNA), not just “burned for heat.” The somatic mutation theory is challenged: mutations may be smoke damage, not the fire. Nuclear transfer experiments (as described): “bad nucleus + healthy mitochondria” stays normal; “healthy nucleus + damaged mitochondria” trends cancerous → hardware over software framing. “Oncogenic paradox” solved metabolically: diverse carcinogens share a common effect—they damage respiration. Treatment implication: press-pulse = chronic glucose restriction + intermittent glutamine inhibition, tracked via GKI. Metastasis idea discussed: fusion-hybridization with macrophage-like traits enabling movement, powered by fermentation → press-pulse could, in theory, pressure those cells too. Closing theme: energy maintains cellular order and identity; without efficient respiration, cells revert toward chaos/growth mode. - Episode timeline 0:19 – 1:13 — Hook: cancer as “bad luck” vs energy code failure; why metabolic framing changes prevention/treatment 1:17 – 1:59 — Source setup: 2025 mini-review; Warburg → Seyfried → “press-pulse” teased 2:00 – 3:24 — Warburg’s 2-step model: OXPHOS damage → aerobic fermentation (lactate with oxygen present) 3:31 – 4:31 — Why it became controversial: oxygen-consumption argument shifts field toward genetics 4:35 – 5:21 — Aha: oxygen use can be misleading; “engine revving in neutral” → ROS “exhaust,” uncoupling 5:24 – 6:57 — The “missing energy” solved: second backup generator MSLP using glutamine; succinate as waste 7:03 – 7:58 — PKM2 bottleneck: rerouting fuel into building blocks (growth materials) 8:02 – 10:23 — Genetics challenged: somatic mutation theory reframed; nuclear transfer experiments; mutations as downstream 10:35 – 12:33 — “Oncogenic paradox”: many causes share one commonality—mitochondrial respiratory damage; microscopy visuals (cristae loss) + lipid droplets as fuel pile-up 12:55 – 14:59 — Treatment payoff: press-pulse (KMT press on glucose + pulsed glutamine inhibition); GKI tracking 15:05 – 15:58 — Metastasis concept: fusion-hybridization with immune cells; fermentation-fueled spread; why press-pulse could matter 16:02 – 17:34 — Final recap + philosophy: respiration maintains differentiation; energy = order/identity - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOL

Most of us think of skin as a wrapper on our body; something to moisturize, protect, and maybe “anti-age.” But this Deep Dive flips that assumption: your skin is a major metabolic organ, and the mitochondria inside the outer layer (the epidermis) may influence far more than wrinkles. In this episode, we break down research suggesting that epidermal aging is driven primarily by mitochondrial decline(a “battery problem”), not classic senescent “zombie cells.” Then the real shocker: when the skin’s mitochondrial furnace goes offline, the body may burn less fat, store more adipose tissue, and show higher fasting blood glucose—even when everything else looks “normal.” We explore the elegant mouse model that isolated skin mitochondrial failure, the downstream effects (hair thinning, delayed wound healing), and why this research strengthens the case for mitochondrial-support strategies—from targeted nutrients to photobiomodulation principles that aim to stimulate ATP production via cytochrome c oxidase. (Educational content only, not medical advice.) - Article Discussed in Episode: Aging-Associated Mitochondrial Decline Accelerates Skin Aging and Obesity - Key Quotes From Dr. Mike: “What if what you’re looking at (the skin) is actually a massive metabolic engine?” “The batteries inside those cells might dictate not just how old you look, but how your entire body processes energy.” “It’s not just aesthetics — it’s about keeping the engine running.” “This paper really forces us to rethink what anti-aging actually means.” “It’s not just vanity… it is metabolic healthcare.” - Key points Skin isn’t just a barrier—it’s a metabolic engine that can influence systemic energy handling. The paper reframes anti-aging: it’s not only aesthetics—it’s “keeping the engine running.” Classic skin-aging model focuses on the dermis: collagen/elastin loss + senescent “zombie cells.” New pivot: the epidermis may age differently—not via senescence, but via mitochondrial depletion. Aged epidermis showed no rise in p16INK4A (a common senescence marker), but showed lower mitochondrial DNA content. Causation test: researchers created epidermis-specific TFAM knockout mice (mitochondrial replication “key” removed only in skin cells). Result: mice developed premature aging phenotypes—hair loss, follicle atrophy, and delayed wound healing. Metabolic shock: despite “normal” elsewhere, mice with skin mitochondrial dysfunction gained more fat mass(visceral + subcutaneous) and did worse on a high-fat diet. Proposed mechanism: broken epidermal mitochondria reduce fatty-acid beta oxidation—skin stops acting as a fat-burning “sink,” so energy overflows into storage. System-wide impact: mice showed higher fasting blood glucose, implying skin metabolism may influence glucose regulation. Practical implication: different layers, different strategies—dermis may benefit from senescence-targeting, but epidermis needs energy restoration. Environmental stress (UV, pollution, chronic stress) may accelerate mitochondrial decline, making the “metabolic shield” concept even more relevant. - Episode timeline 0:19 – 1:14 — Hook: skin as “wrapper” vs metabolic engine; big claim (aging + weight + blood sugar) 1:14 – 2:35 — Paper intro (Yamamura et al.); mission: epidermal mitochondria → domino effect across body 2:35 – 3:33 — Classic model: dermis aging = collagen loss + senescent “zombie cells” 3:33 – 4:30 — Key finding: epidermis isn’t senescent (p16INK4A not elevated); instead mitochondrial decline 4:30 – 5:10 — “Energy crisis” framing; correlation vs causation question 5:10 – 6:09 — Causation experiment: epidermis-specific TFAM knockout (“ignition key” removed only in skin) 6:09 – 7:51 — Phenotypes: hair loss, follicle atrophy, delayed wound healing; “energy drop comes first” 7:51 – 10:42 — Obesity connection: weight gain on normal diet, more fat mass; mechanism = reduced beta oxidation in skin 10:42 – 11:34 — “Skin as energy sink” model; overflow into adipose storage 11:34 – 12:33 — Blood glucose increase; skin as systemic metabolic regulator 12:33 – 14:22 — Interventions mentioned (e.g., L-carnitine); PBM tie-in via cytochrome c oxidase → ATP 14:22 – 15:56 — Strategic shift: senolytics for dermis vs recharge epidermal mitochondria 15:56 – 17:07 — 3 pillars recap: battery-driven epidermal aging; physical consequences; systemic metabolic shock 17:07 – 18:34 — Environmental stress accelerant (UV, pollution, stress) + “metabolic shield” framing - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

We obsess over inputs — keto vs vegan, organic vs processed — like the body is a simple engine: better fuel in, better performance out. But this Deep Dive flips the model: your body is an ecosystem, and your gut microbes are the mechanics. In this episode, we decode how dysbiosis and leaky gut can trigger inflammaging, suppress mitochondrial function, and create the “energy crisis” that feels like aging. Then we explore the real plot twist: many “healthy” phytochemicals aren’t the magic—their microbial metabolites are. We break down the all-star compounds (urolithin A, sulforaphane, equol, hesperetin, SCFAs like butyrate), why conversion depends on your personal metabotype, and what to do if your internal “factory” is missing key workers; starting with dietary diversity, synbiotics, and (in some cases) direct metabolite supplementation. (Educational content only, not medical advice.) - Article Discussed in Episode: Promotion of Healthy Aging Through the Nexus of Gut Microbiota and Dietary Phytochemicals - Key Quotes From Dr. Mike: “The road to mitochondrial health is paved through the gut.” “The body isn’t a machine, it’s an ecosystem… and your microbiome? They’re the mechanics.” “If the gut is chaotic, the whole energy system of the body crashes.” “Phytochemicals aren’t the cleaning crew… they’re the managers.” “The future of longevity might be about rehiring the staff we fired.” - Key points The old model is outdated: It’s not just what you eat, it’s who eats it with you (your microbiome). Healthspan > lifespan: More years aren’t the goal, more capable years are. Aging’s silent driver: Dysbiosis → leaky gut → LPS leakage → chronic inflammation (“inflammaging”). Energy code connection: Inflammation pushes mitochondria into “war mode” (less efficient ATP, more free radicals). Phytochemicals aren’t just antioxidants: At real blood levels, they often act more like signaling managers than “free radical sponges.” Two master switches: NF-κB = master inflammatory alarm NRF2 = master cellular defense/antioxidant program The plot twist: Many polyphenols are poorly absorbed; bacteria convert them into more potent metabolites. All-star metabolites: Urolithin A (from ellagitannins) → mitophagy Sulforaphane (from glucoraphanin; needs myrosinase) → NRF2 activation Equol (from daidzein in soy) → SERM-like benefits (skin/bone/cardiometabolic) Butyrate (SCFAs) → strengthens gut barrier + supports gut-cell mitochondria Hesperetin → neuroprotection potential (BBB relevance mentioned) Metabotype reality: Same food, totally different outcome depending on your microbes (A/B/0 patterns). Practical strategy: Build the factory: plant diversity + synbiotics, and when needed bypass the factory via direct metabolite supplements. - Episode timeline 0:19 – 1:12 — Deep Dive intro + the “inputs” obsession (diet as a combustion engine) 1:12 – 2:24 — The paradigm shift: body as ecosystem; microbiome as “mechanics”; healthspan framing 2:24 – 3:14 — Gut as energy control center: it signals mitochondria, not just feeds them 3:14 – 4:18 — Dysbiosis explained + fortress/garden analogy; diversity loss with age/lifestyle 4:18 – 5:42 — Leaky gut → LPS → systemic inflammation (“inflammaging”) → mitochondrial suppression/“war mode” 5:42 – 6:46 — Phytochemicals redefined: not direct antioxidants; signaling molecules 6:46 – 7:56 — The two switches: NF-κB down, NRF2 up (capacity building vs “mopping”) 7:56 – 9:31 — The plot twist: poor absorption; bacteria convert phytochemicals into potent metabolites 9:31 – 10:54 — Urolithin A: ellagitannins → bacterial conversion → mitophagy 10:55 – 12:08 — Sulforaphane: myrosinase + cooking caveat; gut conversion if enzyme is destroyed 12:08 – 12:58 — Equol: soy controversy reframed; SERM-like benefits 12:58 – 13:38 — Hesperetin + SCFAs (butyrate): BBB relevance + gut barrier fuel 13:38 – 15:26 — Metabotypes: why “superfoods” work for some and not others (A/B/0; equol producers 20–30% in West) 15:26 – 16:44 — Fixing the factory: Mediterranean-style diversity; prebiotics; synbiotics (“worker + lunchbox”) 16:44 – 17:26 — Bypassing the factory: direct metabolite supplementation (urolithin A; equol likely next) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

The dental drill may be the most iconic sound in healthcare—but this deep dive argues it doesn’t have to be the future. Drawing from a 2026 review paper (“Photobiomodulation in Dentistry”) in the International Journal of Advanced Research, we break down how “cold” red and near-infrared light (PBM) can donate energy to oral tissue, boost ATP production via mitochondrial cytochrome-c oxidase, and trigger repair signaling—without heat, cutting, or drugs. We explore why a temporary ROS spike can be helpful (hormesis), how PBM can reduce pain by calming nerve excitability and inflammation, and why this matters for real dental problems: TMJ pain, post-extraction soreness, dry socket, sensitivity, whitening discomfort, faster implant integration, and even orthodontic discomfort. Finally, we talk home devices—why wavelength + dose accuracy matters—and the wild frontier: PBM-assisted regenerative endodontics that could someday bring a tooth “back to life.” (Educational content only, not medical advice.) - Article Discussed in Episode: PHOTOBIOMODULATION IN DENTISTRY: CURRENT EVIDENCE AND FUTURE DIRECTIONS - Key Quotes From Dr. Mike: “What if the future of oral health isn’t about cold steel drills or chemical drugs—what if it’s light?” “PBM is the polar opposite of hot lasers. It doesn’t cut. It donates energy to tissue.” “PBM isn’t a painkiller that masks the problem—it changes the tissue environment so the problem resolves.” “Inflammation is the fire in the gums—and PBM turns the fire down.” “The body wants to heal—sometimes it just needs the right signal to get started.” - Key points Dentistry is shifting from “repair after breakdown” (drill/fill) to bioenergetic healing (signal the tissue to regenerate). PBM = “cold laser / LED therapy,” not the hot surgical lasers that cut or vaporize tissue. Typical therapeutic wavelengths discussed: red + near-infrared (~650–1000 nm). Core mechanism: light is absorbed by cytochrome-c oxidase (mitochondrial “solar panel”) → faster electron transport → ATP spike. PBM can create a brief low-level ROS increase that acts as repair signaling (like exercise stress). PBM may shift cells from glycolysis (low efficiency) toward oxidative phosphorylation (high efficiency)—from “survival mode” to “repair mode.” Pain benefits: PBM can modulate nerve transmission, reduce neural excitability, and lower pain signaling locally. Inflammation benefits: PBM can lower pro-inflammatory cytokines (e.g., IL-1, TNF-α) and increase anti-inflammatory signaling (e.g., IL-10). TMJ: PBM is highlighted as a strong non-drug option that can reduce muscle sensitivity and improve jaw movement. Implants: PBM may help osseointegration by stimulating osteoblasts and angiogenesis—faster stabilization, shorter “danger zone.” Dry socket: PBM may beat “patch” approaches by accelerating real closure via immune cell migration and repair. Sensitivity + whitening: PBM may reduce dentin hypersensitivity via neural hyperpolarization and can be used prophylactically before bleaching to reduce pulp irritation. Home PBM is rising, but dosimetry matters: wrong wavelength/power = pretty red glow, weak biology. Future frontier: PBM may stimulate dental pulp stem cells—regenerative endodontics rather than “dead tooth root canals.” - Episode timeline 0:00–0:54 — The dental fear hook Drill sound, antiseptic smell, the “universal phobia,” and why the paradigm may change. 0:54–1:24 — The promise “What if the most powerful tool is light?” + introduce the 2026 dentistry PBM review paper. 1:24–2:19 — PBM basics (what it is / isn’t) PBM vs “hot” surgical lasers; cold laser / LED therapy; wavelength range. 2:19–3:36 — Big reframing Teeth aren’t rocks—mouth is living tissue that can be optimized. 3:36–6:20 — Core mechanism: mitochondria → ATP Cytochrome-c oxidase as chromophore; electron transport chain; “fast charger” analogy; universal mechanism (oral tissue = same engine). 6:20–8:53 — ROS nuance + metabolic upgrade Temporary ROS spike as signaling; hormesis; glycolysis → oxidative phosphorylation (“scooter to Ferrari”). 8:53–11:47 — Pain + inflammation + TMJ Local nerve modulation, cytokines, “blanket over alarm bell”; TMJ outcomes (movement + muscle sensitivity). 11:49–13:13 — Bone + implants Osseointegration; osteoblasts + angiogenesis; faster stabilization. 13:13–14:31 — Dry socket Why it hurts; conventional paste vs PBM-driven repair acceleration. 14:31–15:16 — Ortho angle Reduced tightening pain; possible speed-up of tooth movement (noted variability). 15:16–17:52 — Sensitivity + whitening preconditioning Dentin hypersensitivity; neural hyperpolarization; PBM before bleaching to reduce pulpal pain. 18:00–20:10 — Home devices + dose accuracy warning Trend toward home PBM; dosimetry, irradiance, wavelength precision; “right key opens the lock.” 20:10–21:23 — Stem cells + regenerative endodontics Dental pulp stem cells; proliferate/differentiate; “bring it back to life” future. 21:23–23:15 — Wrap + big question Bioenergetic vs chemical

In this solo episode of The Energy Code, Dr. Mike Belkowski introduces BioElixir, a new supplement line built around one core idea: focus is not a personality trait, it’s brain energy as biology. You’ll get a transparent, ingredient-by-ingredient breakdown of BioElixir MIND: what each compound is, why it’s in the formula, what human research does (and doesn’t) support, and how to think about dosing evidence in multi-ingredient stacks. Mike frames “brain energy” as a full chain: mitochondrial ATP output, membrane integrity, neurotransmitter signaling, stress chemistry, hydration, blood flow, and waste clearance. From cholinergics (Citicoline + Alpha-GPC) and membrane support (phosphatidylserine), to mitochondrial throughput (ALCAR + creatine/cregaatine + PQQ), stress resilience (tyrosine, rhodiola, ginseng, saffron), neuro-supportive mushrooms (lion’s mane, ergothioneine), and foundations like shilajit and Litewater deuterium-depleted water, this episode is designed to be education-first, hype-last. Mike closes with practical use cases (morning, cognitively intensive work, avoiding “caffeine train”), why he kept the formula natural (no methylene blue), packaging details (Miron violet glass), flavoring notes (pomegranate to mask bitterness), and the launch promo (first-week discount + subscription stacking). Key Quotes From Dr. Mike “If the brain cannot generate ATP efficiently… you’ll feel like you’re driving a sports car with no fuel.” “A brain-energy stack has to reduce the drain, not just push the gas pedal.” “Creatine is in the BioElixir MINDmore or less as a brain battery buffer. It’s not a stimulant; think of it as a reserve tank.” “Focus isn’t willpower. It’s mitochondrial throughput plus clean signaling.” “You don’t need jitters. You need stable voltage.” Key Points Framework: a real brain-energy formula must support mitochondrial output + signaling efficiency + protection from age-related wear and tear, not just stimulation. Evidence honesty: many studies use higher single-ingredient doses than multi-ingredient blends; that doesn’t make blends “bad,” it changes how we interpret results. Cholinergic stack: Citicoline (CDP-choline) supports acetylcholine + membrane substrates; Alpha-GPC is highly bioavailable and often studied in impairment contexts. Together = “messaging + hardware.” Membrane integrity matters: Phosphatidylserine framed as a key but overlooked lever for clean signaling. Mitochondrial throughput: Acetyl-L-carnitine supports fatty acid transport into mitochondria and is positioned as fatigue-to-clarity support. ATP buffer: Creatine (and the formula’s “cregaatine” variant) positioned as a reserve tank for high-demand or sleep-deprived cognition. Stress cognition: L-tyrosine is framed as “best when stress depletes catecholamines,” not a “more dopamine = genius” hack. Long-game neuro support: Lion’s mane and ergothioneine positioned as supportive while used, not instant “20-minute” stimulants. Cognitive outcomes ingredient: PQQ and “PQQ disodium salt” discussed as having controlled cognitive data in aging-adjacent groups (as presented in the transcript). Adaptogens with nuance: Rhodiola and red Korean ginseng described as stamina/resilience supports; results can be mixed depending on extract + population. Mood-cognition link: Saffron included because mood and cognition are inseparable. Taurine realism: human evidence is mixed for dementia protection; taurine framed as stability + calcium handling more than “main driver.” Foundation ingredients: Shilajit (fulvic acids, energy/fatigue signals) + Litewater DDW (lower deuterium to support enzyme kinetics/mitochondrial efficiency) form the “base layer.” Product usage: 10–12 pumps per serving; stable/smooth energy without jitters; flexible timing (morning or before deep work). Launch details: first-week promo + subscription stacking; flavor is pomegranate to mask bitter herbs. Episode Timeline 1:55–2:58 | Disclaimers + brain-energy framework Education only; dosing vs studies; how to interpret evidence. Brain energy chain: ATP, water/hydration, blood flow, glymphatic waste, stress chemistry. 3:34–7:49 | Cholinergics + membrane ‘hardware’ Citicoline (CDP-choline): acetylcholine + phospholipid substrates; memory trial mentioned. Alpha-GPC: bioavailable; more evidence in impairment/dementia contexts; why both together. 7:49–9:31 | Phosphatidylserine Membrane integrity + signaling; trial in MCI blend noted. 9:31–11:03 | Mitochondrial throughput: ALCAR Fatty acid transport + fatigue/cognition signals in older adults. 11:03–12:07 | BioLight bundles promo segment Bundles, what’s in each, 20% off + shipping discount. 12:26–15:07 | Creatine + Tyrosine Creatine as ATP buffer under stress/sleep deprivation. Tyrosine as stress-performance support (not “dopamine genius”). 15:07–17:29 | Lion’s mane + PQQ (as presented) Lion’s mane MCI trial pattern: benefits reduce after stopping. PQQ described as memory/attention support in aging-adjacent studies. 18:13–22:5

For years, we obsessed over the invader: spikes, variants, antibodies, immune escape. But this deep dive flips the lens to the terrain, the battlefield inside the body, and the batteries powering it. Using a 2025 paper from the Journal of Medical Virology on genetic landscape + mitochondrial metabolic dysregulation in severe long COVID, we unpack a provocative idea: long COVID can look like a metabolic crash in people with hidden, common genetic weak links in their energy chain. These aren’t obvious rare childhood disorders. Many patients appear healthy until the virus hits like a stress test. The infection forces a cellular shift from efficient oxygen-based energy (OXPHOS) to quick-and-dirty sugar burning (glycolysis). Most people switch back. In severe long COVID, the system can get stuck. We walk through the study’s patient profile (brain fog, hypersomnia, myopathy), the genetics (dozens of mitochondria-related variants, including hits like POLG, MIPEP, ACOT9), and the functional data (Seahorse XF “live engine audit” showing either crashed ATP production or hypermetabolic redlining). Then we connect the dots to oxidative stress signals like SOD2 roaring like fire trucks that never leave. Bottom line: this frames long COVID as physically real, bioenergetic, and potentially predictable — shifting medicine’s focus from “invader only” to metabolic resilience. (Educational content only, not medical advice.) - Article Discussed in Episode: Genetic Landscape and Mitochondrial Metabolic Dysregulation in Patients Suffering From Severe Long COVID - Key Quotes From Dr. Mike: “We’ve been completely obsessed with the invader… but we’ve largely ignored the terrain.” “The battlefield is our own bodies… the actual batteries that power that battlefield.” “The difference between bouncing back in a week versus suffering for years… isn’t random.” “Long COVID might actually be a metabolic crash in someone who is genetically susceptible.” “The virus acts as a stress test… a pressure cooker that exposes the weak link.” - Key points The pandemic lens has been invader-first; this episode is terrain-first (the host battlefield). Severe long COVID symptoms cluster in brain + muscle — the body’s top energy consumers. SARS-CoV-2 can interact with mitochondrial proteins and push metabolism toward glycolysis. The study profiled 13 severe long COVID patients with primarily neuro-muscular symptoms. Whole-genome sequencing found many mitochondrial-related variants (not one “smoking gun”). Key idea: heterozygous variants can be silent until a major stressor hits. The episode’s core concept: synergistic heterozygosity = multiple small weak links that fail together under stress. Example genes discussed: POLG (mtDNA replication), MIPEP (mitochondrial protein maturation), ACOT9 (fatty acid metabolism). Seahorse XF bioenergetics showed two failure modes: Crash: ATP production “on the floor” (dead batteries). Redline: hypermetabolism (engine revving itself to burnout). Proteomics showed SOD2 upregulation — a loud signal of ongoing oxidative stress. Some patients showed downregulation of electron transport chain proteins (mechanical breakdown). Clinical implication: standard labs can look normal while the real issue is mitochondrial function. Provocation: in some cases, metabolic resilience may matter as much as (or more than) antibodies for recovery trajectory. - Episode timeline 0:00 – 0:48 | The pivot: invader → terrain Shift from tracking the virus to examining the battlefield and energy capacity. 0:48 – 1:58 | The paper + the thesis 2025 Journal of Medical Virology paper. Long COVID framed as a metabolic crash with genetic susceptibility. 1:58 – 3:10 | Who the patients are (severe profile) 13 patients, severe neuro-muscular symptoms: fatigue, brain fog, hypersomnia, myopathy. Why brain + muscle crash first: energy demand. 3:10 – 5:12 | Viral metabolism hijack SARS-CoV-2 binds mitochondrial proteins, suppresses mitochondrial function. OXPHOS → glycolysis shift; for some, the switch never resets. 5:12 – 6:42 | Genetics: not one gene, many weak links Whole genome sequencing. Many variants in mitochondrial-related genes; some classified pathogenic/likely pathogenic. Why they weren’t sick before: heterozygous “backup power.” 6:42 – 8:37 | Core concept: synergistic heterozygosity Car/Indy 500 analogy. Example genes: POLG, ACOT9, MIPEP. 8:37 – 10:35 | Functional testing: Seahorse XF “Live engine audit” of oxygen consumption/ATP. Patient P4 “double hit” with very low ATP. Others show hypermetabolism (“redlining”). 10:35 – 12:38 | Proteomics + oxidative stress signals SOD2 upregulation = fire trucks outside the building. Downregulation of electron transport chain proteins in some patients. 12:38 – 15:05 | Clinical blind spot + big provocation Why routine labs miss it; fatigue dismissed. Terrain/resilience framing and implications for future medicine. - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating p

Most heart conversations start and end with plumbing: clogged arteries, cholesterol, blood pressure. This one doesn’t. In this Energy Code Deep Dive, we go straight to the true engine of the heart: mitochondria. Why do heart cells devote nearly a third of their space to these “power plants”? Because your heart never stops, and energy is the real limiting factor. When mitochondria lose their ability to fuse, split, and recycle damage, the heart’s power grid becomes clogged with broken “zombie engines.” Then the real plot twist hits: damaged mitochondria leak DNA that looks bacterial, triggering the immune system to panic and ignite chronic inflammation. That sterile inflammation hardens the heart, disrupts rhythm, and accelerates aging from the inside out. And the best part: if cardiac aging is an energy-maintenance problem, you have leverage. We unpack the two-front strategy: improve mitochondrial efficiency and restore cellular cleanup. This is the why behind tools like photobiomodulation and lifestyle levers that re-balance mTOR and AMPK — so the janitor can come back to work. (Educational content only, not medical advice.) - Article Discussed in Episode: Heart of the matter: Mitochondrial dynamics and genome alterations in cardiac aging - Key Quotes From Dr. Mike: “Mitochondria are the government, the waste management system, and the power grid all rolled into one.” “When mitochondria start to fail, the heart doesn’t just run out of gas — the control system starts to glitch.” “As we age, the sanitation department goes on strike.” (Alluding to decreased mitophagy activation) “The heart is attacking itself because its own engines are leaking parts that look like an enemy.” “If we can seal the leak and clean the engine… how much of aging is actually reversible?” - Key points We’ve been treating symptoms, not root cause: heart aging isn’t just “pipes and pumps,” it’s an energy failure problem. The heart is an ATP monster: it beats ~100,000 times/day and is heavily mitochondrial by design. Mitochondria aren’t static beans: they’re a dynamic network constantly fusing and splitting (fusion/fission) to stay resilient. Fusion = resource sharing: mitochondria merge to dilute damage and stabilize function. Fission = quality control: mitochondria split to isolate damaged segments for removal. Aging breaks the rhythm: too much fusion or too much fission both impair output and resilience. Mitophagy is the sanitation system: damaged mitochondria must be recycled; aging slows this cleanup. Why cleanup fails: mTOR runs too “build-mode,” AMPK runs too low, so the janitor gets sent home. mtDNA is fragile: mitochondrial DNA sits next to the furnace and accumulates errors, creating a mosaic of function (heteroplasmy). “Blue cells” become conduction roadblocks: a small number of defective cells can disrupt the heart’s electrical wave. The big twist — inflammaging: damaged mitochondria leak DNA that looks bacterial → the immune system triggers sterile inflammation. Inflammation fuels fibrosis + senescence: stiffening, dysfunction, and “zombie cells” secreting toxic signals. Actionable thesis: protect mitochondrial integrity by boosting efficiency + restoring cleanup (energy + recycling). - Episode timeline 0:19 – 1:30 | The reframe Heart health isn’t plumbing. It’s energy and what happens when that currency gets devalued. 1:30 – 3:25 | Why the heart is a mitochondrial machine The heart’s nonstop workload and massive ATP demand. Mitochondria as regulators (ATP, calcium handling, survival signals). 3:25 – 5:25 | Mitochondrial dynamics: the “dance” Fusion (share resources, dilute damage) vs fission (isolate damage, multiply). What goes wrong when the rhythm breaks. 5:25 – 7:50 | Mitophagy: taking out the trash How aging slows cleanup. mTOR too high + AMPK too low = “janitor goes home.” 7:50 – 9:40 | The vulnerable blueprints (mtDNA + heteroplasmy) Why mtDNA is more fragile than nuclear DNA. Mosaic tissue function and “blue” defective cells disrupting conduction. 9:40 – 12:40 | The plot twist: inflammaging via mitochondrial leaks Leaky mitochondria release DNA that resembles bacteria. False infection alarm → innate immune activation → chronic sterile inflammation. Fibrosis and senescence (“zombie cells” + toxic secretions). 12:40 – 14:45 | What to do: fix the code Maintain mitochondrial integrity. Boost mitophagy and efficiency (two-front strategy). PBM + fasting/time-restricted eating as examples of “clean + charge.” 14:45 – 16:07 | Closing provocation “Aging as mistaken identity.” If we can seal leaks and restore cleanup, what’s reversible? - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Age-related macular degeneration isn’t just an “eye problem.” In this deep dive, we frame age-related macular degeneration as a bioenergetic failure: retinal tissue has extreme energy demand, mitochondria slow down with age, waste accumulates, and the system gradually starves into cell death. We unpack a real-world 2025 clinical dataset using photobiomodulation with multi-wavelength light aimed at a mitochondrial “ignition switch,” discussing why red and near-infrared support ATP production while yellow targets oxidative stress and debris handling. Then we get practical: the study treated early dry AMD patients who still had decent vision (around 20/32) and found something rare in degenerative disease care — stability, and in many cases improvement, especially with ongoing maintenance “top-ups.” Finally, we zoom out: if the retina is neural tissue, what might this imply for brain conditions linked to mitochondrial dysfunction? (Educational content only, not medical advice.) - Article Discussed in Episode: Multiwavelength Photobiomodulation Improves Multiple Aspects of Visual Function in Early-Stage Dry Age-Related Macular Degeneration - Key Quotes From Dr. Mike: “Dry AMD is the slow starvation of retinal cells.” "The retina is a bioenergetic system. When the fuel system breaks down, vision fails." “Time is tissue. Once retinal tissue is dead, it is gone forever.” “Early intervention doesn’t just delay the end. It improves the whole trajectory.” “Red and near-infrared fuel the engine. Yellow cleans the exhaust pipe.” - Key points The episode reframes AMD as a ticking clock driven by cellular energy failure, not just optics. Conventional early dry AMD guidance is portrayed as “watch and wait” (vitamins + follow-up after decline). The retina is neural tissue with massive metabolic demand; when mitochondria falter, retinal cells can enter apoptosis. PBM uses targeted wavelengths matched to mitochondrial absorption (focus on cytochrome c oxidase as the “ignition switch”). Mechanism described: red/near-infrared light helps dislodge nitric oxide interference, improves oxygen utilization, and boosts ATP output. Multi-wavelength logic: red + NIR for “fuel,” yellow for “cleanup.” The system referenced (Valetta system) uses ~590 nm (yellow), 616 nm (red), and 850 nm (NIR). Study context: retrospective, real-world clinic setting in Turkey; 27 patients / 41 eyes, average age ~72, starting around 20/32. Core philosophy: “Time is tissue” — treat while tissue is viable, before geographic atrophy (“sinkhole”) forms. Protocol: 9 sessions over ~3–5 weeks; a maintenance cohort repeated the series every 4 months. Outcomes emphasized: In maintenance group, ~34.6% gained 5–10 letters. Most striking: 0 eyes lost vision over follow-up (up to ~16 months). Improvements in contrast sensitivity (real-world quality of vision). Objective confirmation via ERG (stronger electrical retinal response). Practical take: PBM is framed as chronic care (like going to the gym): sustained input sustains output. - Episode timeline 0:19–1:54 — The problem + the frustration AMD framed as a ticking clock “Watch and wait” critique: vitamins + passive follow-up 1:54–2:34 — The pivot “Flip the script”: intervene by supporting the eye’s energy system Light as a “battery recharge” concept 2:34–4:16 — Why the retina is vulnerable Retina as neural tissue with high metabolic demand Mitochondrial decline → waste leakage → apoptosis → dry AMD as slow starvation 4:16–6:52 — PBM mechanism + the wavelength “cocktail” Targeting cytochrome c oxidase Red/NIR for ATP; yellow for cytoprotection/waste handling “Fuel the cell, clean the cell” 6:59–8:47 — The human study design Retrospective Turkey cohort: 27 patients / 41 eyes; avg age ~72 Starting vision ~20/32 “Time is tissue” rationale for early intervention 8:48–10:55 — Protocol + headline outcomes Cohort 1: one series (9 sessions) Cohort 2: series + maintenance every 4 months Improvements (letters gained) + the standout: 0 eyes worsened 11:00–12:52 — Quality of vision + objective verification Contrast sensitivity improvements ERG as objective “voltmeter” confirmation (stronger signal) 12:54–14:17 — Real-world adherence + why maintenance matters Time commitment discussed Chronic care analogy: gym/dialysis Benefits fade without ongoing inputs 14:17–15:06 — Safety Zero adverse events; no phototoxicity/pain; no negative choroid thickness changes Compared against invasive wet AMD injections 15:06–16:58 — Bigger implications “Bioenergetic support” as a new medical frame Retina-as-brain-tissue → potential relevance to neural degeneration 16:58–18:18 — Closing + call to action “Light vitamins” framing If family history or “watch & wait,” ask about energy-first strategies - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social me

What if fertility isn’t primarily a hormone problem, but an energy problem? In this Deep Dive, we connect two dense pieces of research: a 2022 aspartame toxicity study and a 2025 review on ovarian aging mechanics. Together, they paint an unsettling picture: common “sugar-free” habits may trigger a silent mitochondrial crisis in the ovary, raising oxidative stress, suppressing key antioxidant defenses, and pushing the egg-support system into a metabolic panic that can resemble accelerated aging. We break down the “energy code” of egg quality: why the oocyte has a hard ATP threshold, how oxidative stress damages cellular machinery, why the ovary may try (and fail) to compensate by making more mitochondria, and what practical steps may matter most: remove the interference, then rebuild the energy capacity (including a discussion of photobiomodulation as a mitochondrial-support tool). We end with a provocative question: if mitochondria are maternally inherited, are we only affecting fertility — or potentially the “battery quality” of future generations? (Educational content only, not medical advice.) - Articles Discussed in Episode: The impact of mitochondrial dysfunction on ovarian aging Aspartame Consumption, Mitochondrial Disorder-Induced Impaired Ovarian Function, and Infertility Risk - Key Quotes From Dr. Mike: “Aspartame is a mitochondrial toxin in the context of ovarian health.” “It’s not random bad luck — it’s a dose-response pattern tied to (aspartame) consumption.” “The ovary tried to fight back… but you can’t build good engines in a poisoned factory.” “Egg quality isn’t just quantity — it’s whether the remaining eggs have the power to run.” “You can’t supplement your way out of a toxic environment.” - Key points Fertility is framed here as a mechanic’s problem: the “engine” (oocyte + mitochondria) stalls when cellular energy fails. A highlighted human finding: ~1.79× increased infertility risk under 35 with aspartame consumption, with a dose-response pattern. Aspartame is described as a mitochondrial toxin via oxidative stress: more “smoke” (ROS), fewer “cleaning crew” enzymes (catalase, SOD2). Damage signals referenced: 8-OHdG (DNA damage) and MDA (lipid peroxidation) — “cell walls going rancid.” A “compensatory trap”: the ovary may spike mitochondrial biogenesis signals (SIRT1/PGC-1), but ATP capacity still drops (more engines, worse output). The 2025 ovarian aging review emphasizes egg quality as mitochondria-dependent, not just egg count. A key threshold mentioned: if oocyte ATP drops below ~100 ng/µL, fertilization rates fall below ~30%. Aging-like mechanisms include ROS imbalance, mitochondrial membrane dysfunction, apoptosis signaling, and calcium signaling chaos that can arrest development. Practical “protocol” framing: 1) Eliminate the toxin exposure (check labels), 2) Support mitochondrial functionto improve ATP/ROS balance. - Episode timeline 0:19–1:24 — Opening + the premise “Energy code” applied to reproductive health Two papers: 2022 aspartame toxicity + 2025 ovarian aging mechanics 1:25–3:18 — The headline finding + why it matters 1.79× infertility risk under 35 (time-to-conceive metric; infertility = >12 months) Dose-response: more aspartame → harder to conceive “The trap”: no major weight gain, but internal metabolic damage 3:19–5:37 — The mitochondrial toxin mechanism Oxidative stress framing: mitochondria = factory, ROS = smoke Antioxidant enzymes (catalase, SOD2) suppressed Damage markers: 8-OHdG (DNA), MDA (lipid peroxidation) 5:38–7:13 — The compensatory trap Biogenesis signals spike (SIRT1/PGC-1): “build more engines” But ATP production capacity still drops: “crowded dysfunctional factory” 7:14–10:12 — Ovarian aging mechanics + why eggs are uniquely vulnerable Mitochondria as the oocyte “power plant” + genetic bottleneck Hard ATP threshold (~100 ng/µL) tied to fertilization rates Errors when ATP is low: meiotic failure → chromosomal issues / arrest 10:13–12:37 — Granulosa cells + ROS/apoptosis/cell-signaling problems Granulosa cells as pit crew; mitochondrial shape changes in aging ROS imbalance → membrane leak → apoptosis signaling Calcium signaling: mitochondria as “storage tanks”; oscillation chaos → arrest 12:38–13:18 — The overlap conclusion Aspartame mechanisms mirror ovarian aging drivers (ROS, antioxidant decline) Insulin resistance as an aggravator: “pouring gasoline on the fire” 13:24–15:56 — Listener application: the protocol Step 1: eliminate aspartame (hidden sources: gums, powders, “sugar-free” drinks) Step 2: rebuild the ratio (lower ROS, raise ATP) Tools discussed: photobiomodulation + mitochondrial support ethos at BioLight.shop 15:57–18:04 — Recap + the lineage-level question Maternally inherited mitochondria: are we passing down “weak batteries”? Call to action: check labels, protect mitochondria, rebuild energy capacity - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) B

What if aging isn’t a slow fade… but a mechanical feedback loop running inside every cell? In this deep dive, we break down a 2025 review on the telomere–mitochondria connection and why longevity is not just about “longer telomeres” or “better mitochondria” as separate ideas. They’re locked in a two-way conversation, and when one system slips, it can sabotage the other. You’ll learn how mitochondrial “exhaust” (ROS) can chemically damage telomeres even without cell division, why the DNA guardian p53 can accidentally make the problem worse by suppressing mitochondrial repair, and how TERT(telomerase’s active subunit) may “moonlight” inside mitochondria as a defense mechanism. We also explore the paper’s provocative thread about senescent cells leaking citrate and whether that leak could be a signal that spreads aging through tissue. If you want the practical takeaway in one line: don’t obsess over the clock on the wall — protect the power plant in the basement. - Article Discussed in Episode: Exploring the Link Between Telomeres and Mitochondria: Mechanisms and Implications in Different Cell Types - Key Quotes From Dr. Mike: “Bad energy destroys the genetic clock.” “Aging isn’t the calendar turning a page. It’s a mechanical loop running in the background. “Telomeres don’t just shorten from division — they can get chemically burned down.” “The telomeres panic and call p53… and p53’s response is to fire the maintenance crew.” “Think of ROS like smoke in a building: the longer it hangs around, the more it damages the structure.” - Key points Aging is framed as a feedback loop, not a one-way countdown. Mitochondria produce ROS “exhaust.” When they get inefficient, ROS rises. Telomeres are guanine-rich, and guanine is highly oxidation-sensitive—making telomeres a prime ROS target. Telomeres can fray from oxidative damage even without cell division (“aging while standing still”). Telomere damage triggers DNA damage response (DDR) and activates p53. p53 can suppress PGC-1α/PGC-1β (mitochondrial biogenesis/repair regulators), reducing mitochondrial maintenance. Less repair → worse mitochondria → more ROS → more telomere damage = vicious cycle. TERT may relocate to mitochondria under mild stress, acting like an internal antioxidant/protective factor. Repair systems need NAD+; chronic DNA repair demand can drain NAD+, limiting SIRT1-driven mitochondrial maintenance. Aging cells can shift toward glycolysis (Warburg-like survival mode) and enter senescence. Senescent cells may leak citrate; the paper raises the possibility it’s not just waste but a dysfunction signal. Real-life tie-ins: skin fibroblasts (collagen/visible aging), T-cell immunosenescence, and cancer as the “hacker”that disables p53 and upregulates TERT. Sperm cells are a weird exception: telomeres can lengthen with paternal age, but mitochondrial/ROS balance is fragile. - Episode timeline 0:19–1:12 — Intro: 2025 telomere–mitochondria review framing 1:13–2:56 — Two aging “celebrities” (telomeres + mitochondria) revealed as one linked system 3:16–5:08 — Domino #1: mitochondrial ROS “exhaust” damages guanine-rich telomeres (8-OHdG) 5:19–7:10 — Domino #2: telomere damage → DDR → p53 → suppresses PGC-1 → less mito repair 7:19–9:13 — Potential hero: TERT “moonlights” in mitochondria; NAD+/SIRT1 fuel limits 10:12–11:38 — Metabolic shift: OXPHOS down → glycolysis up → senescence + citrate leak 11:40–13:04 — Real-world examples: skin fibroblasts + immune T-cells (energy limits response) 13:04–13:41 — Cancer as the hacker: p53 disabled, TERT up, glycolysis locked in 13:41–15:45 — Sperm cell exception + “Goldilocks ROS” problem 15:49–16:43 — Practical takeaway: protect mitochondria to protect telomeres 16:50–17:58 — Big question: is citrate a “contagion” signal of aging? Wrap + CTA - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Ever stand up after hours at a desk and your knees sound like a rusty hinge? Or finish a weekend run and feel like your joints mailed you a strongly worded complaint by Tuesday? In this Deep Dive, we unpack a 2025 paper from Discovery Medicine titled “Urolithin B promotes meniscal regeneration and prevents the development of osteoarthritis in mice.” The headline is big: not just less inflammation or less pain signaling, but actual meniscus repair signals in a disease model that normally accelerates joint breakdown. We break down what Urolithin B is, why food sources aren’t reliable for most people, and how this molecule appears to flip joint cells from destruction mode to construction mode by suppressing inflammatory cytokines and tissue-chewing enzymes (like MMP-13) while boosting cartilage-building programs (like SOX9, collagen, and VEGF). We also connect the mechanism to the real-world “why” behind delivering Urolithin B directly (as discussed in the episode). - Article Discussed in Episode: Urolithin B Promotes Meniscal Regeneration and Prevents the Development of Osteoarthritis in Mice - Key Quotes From Dr. Mike: “(Urolithin B) is tackling what many would call the holy grail of joint health… regeneration.” “(Urolithin B) literally flipped the switch from a catabolic breakdown state to an anabolic build-up state.” “You’re not masking a symptom, you’re trying to reboot the regenerative machinery.” “Defend, protect, and rebuild all in one molecule." (In regards to Urolithin B) - Key points The big promise: regeneration — not just symptom relief. What Urolithin B is: a gut-derived metabolite from ellagic-acid-rich foods (pomegranate, walnuts, berries). Why diet isn’t enough for many: large portion of people may be low/non-producers due to microbiome variability. Meniscus 101: fibrocartilage “shock absorber” between femur and tibia; when it fails, OA risk rises fast. Current standard care problem: many options manage symptoms more than they restore tissue. In vitro findings: Urolithin B was non-toxic and calmed IL-1β–triggered inflammatory signaling. Stops the demolition crew: reduced destructive ECM enzymes (highlighted: MMP-13, ADAMTS enzymes). Starts the construction crew: increased cartilage matrix building blocks (collagens, aggrecan). Flips genetic switches: boosted transcription factors tied to cartilage formation (spotlight: SOX6/SOX9). Supports “supply lines”: increased VEGF (angiogenesis signal), relevant given meniscus’ poor blood supply. In vivo mouse OA model: meniscus-injury OA developed as expected in controls; EuroB-treated animals showed less erosion and better structure. Consistent mechanism across dish → animal: inflammatory markers down, matrix destruction down, repair signals up. - Episode timeline 0:00–0:44 — Cold open: creaky joints, “repair the hinge” idea 0:44–1:22 — Episode mission + 2025 paper intro (Urolithin B, meniscus regeneration, OA prevention in mice) 1:34–2:17 — What Urolithin B is + “signal” framing 2:48–4:11 — Meniscus basics, OA problem, limits of symptom-based treatments 4:18–6:12 — Petri-dish phase: safety + IL-1β inflammation model + suppression of cytokines/destructive enzymes 6:18–8:13 — Rebuild signals: collagens/aggrecan, SOX6/SOX9, VEGF, proliferation markers 8:57–10:40 — Mouse OA model: structural improvements + tissue protein markers confirm mechanism 10:48–11:46 — “Triple threat” summary: anti-inflammatory, anti-catabolic, anabolic 11:49–12:55 — Why food conversion is unreliable (microbiome “lottery”) + direct-delivery rationale 12:59–14:31 — Big-picture future: “inducing repair” + closing call-to-action / wrap - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Most people think of health as a game of chemistry and calories. But there is a hidden layer to reality that governs how your biology functions before a single molecule ever moves: subtle energy. In this episode, Nico Martens joins Dr. Mike to pull back the curtain on BioGeometry and vibrational physics. We explore how "The Card", which is a simple-looking tool engraved with sacred geometric symbols, can objectively alter the taste of wine and the energetic quality of a room by tapping into the "unseen" world. Nico explains why our modern environments are "energetically toxic" and how we can use the principles of BioGeometry to harmonize our homes, mitigate EMF stress, and support mitochondrial vitality at a quantum level. Then comes the shift. We move from theory to application, discussing how these subtle forces interact with our physical structure. From clearing the "energetic memory" of hotel rooms to using geometric shapes to balance the body's internal systems, this episode provides a blueprint for tapping into the next evolution of human health. Key Quotes From Nico Martens: “Subtle energy are really all these energies that most of us cannot perceive with our regular senses, but that actually run this entire reality.” “If you go down to the base level and you break it all the way down, there is no physical matter. There's only vibration.” “Your environment is either feeding you or it's depleting you.” “BioGeometry is the language of nature’s design system.” “The answers to all the challenges we face in the physical world... lay in the unseen.” Key Points: The Reality of Subtle Energy: Everything in our physical world is built upon a foundation of energy, vibration, and frequency; if you break matter down to its base level, "physical" matter disappears into vibration. BioGeometry Explained: A science that uses the energy of shapes to balance biological energy systems; it is effectively "tuning" the environment to support life. The "Wine Test": How specific geometric symbols on a card can change the molecular structure and taste of liquids by harmonizing the subtle energy field. EMF & Modern Toxicity: Why our current technology creates "discordant" frequencies that stress our mitochondria and how geometry can "harmonize" these signals. The Power of "The Card": A tool used by practitioners to clear hotel rooms of "energetic debris" and improve the quality of food and water instantly. Biological Balancing: Using specific shapes to center the body’s energy, helping to mitigate the "cellular noise" of the modern world. Episode Timeline: 0:00–4:30 — The Wine Story: How Nico used "The Card" to change Dr. Mike’s wine; intro to Nico’s background. 4:31–15:40 — Nico’s Journey: From the physical world to the quantum; meeting in a creek in Tennessee. 16:40–21:15 — Defining Subtle Energy: Beyond the five senses; why Tesla was right about vibration. 21:30–35:20 — What is BioGeometry? The science of shape, the "BG3" centering quality, and nature’s design language. 35:35–45:10 — Environmental Stress: How EMFs and "dirty" energy impact mitochondrial health and the "Mitochondrial Matrix." 45:25–55:00 — Practical BioGeometry: Harmonizing your home and why your environment is either feeding or depleting you. 55:10–01:10:30 — "The Card" Deep Dive: How it works, what the symbols mean, and how to use it in daily life. 01:10:45–01:30:33 — The Unseen World: Why the next evolution of humanity lies in tapping into these subtle dimensions; closing thoughts. Where to learn more from & about Nico Martens: IG: @nicomartens76 Nico Martens Coaching The Wellness Enterprise - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Most people think head trauma equals concussion. But there’s a silent thief that can ride along with blunt-force injury and steal something just as life-altering: vision. In this Deep Dive, we break down traumatic optic neuropathy (TON): how shockwaves and shearing forces injure the optic nerve at a bony choke point (the optic canal), then trigger swelling, compartment-syndrome-like pressure, ischemia, and a vicious “cellular riot” that kills neighboring neurons in the days that follow. The brutal reality: traditional options like steroids, surgical decompression, or “observation” often lack strong evidence for reliably saving sight. Then comes the twist. We review a 2025 peer-reviewed rat study (21-day follow-up) testing methylene blue (MB)immediately after optic nerve crush. MB acts like an electron “bypass road” in the mitochondrial chain, helping keep ATP online when parts of the system are damaged, while also inhibiting the trauma-driven iNOS nitric-oxide flood that creates destructive peroxynitrite. Functionally, the study shows striking preservation of retinal signaling and retinal ganglion cell function, suggesting that immediate metabolic support may blunt secondary degeneration during the “golden window” after injury. - Article Discussed in Episode: Neuroprotective Effect of Methylene Blue in a Rat Model of Traumatic Optic Neuropathy - Key Quotes From Dr. Mike: “There’s a silent thief that often rides shotgun with these head injuries… your vision.” “The optic nerve… is basically the data cable connecting the camera of your eye to the hard drive of your brain.” “Methylene blue… is for all intents and purposes, artificial respiration for the cell’s engine.” “Methylene blue… can act like a temporary bypass road for the bucket brigade.” “You support the energy, you save the structure, you save the function.” - Key points TON can steal vision after blunt trauma even without a direct eye puncture; the optic nerve is a vulnerable “data cable” through a tight bony tunnel (optic canal). The most devastating loss often comes from secondary degeneration: swelling inside the canal raises pressure, chokes blood flow (ischemia), and triggers a cascading “cellular riot.” Standard care is frustratingly limited: steroids, decompression surgery, or observation are described as controversial with limited hard evidence of superiority. There’s a “golden window” (roughly 14–30 days) where tissue is struggling but not fully dead—yet medicine lacks reliable tools to stop the cascade. Methylene blue is not a random supplement: it’s on the World Health Organization list and has long clinical use (e.g., methemoglobinemia). Mechanism #1: MB acts as an electron cycler, bypassing damaged complexes to keep electron flow and ATP production going during ischemic stress. Mechanism #2: MB inhibits iNOS, helping shut down the runaway nitric-oxide surge that forms peroxynitrite, a highly destructive oxidant. In the rat optic nerve crush model, MB given immediately (and repeated doses over 24 hours) produced major functional preservation on ERG measures (especially inner-retina processing signals) and strong evidence of retinal ganglion cell signal preservation, aligning with better structural survival at 21 days. - Episode timeline 1:38–3:38 — TON explained: vision loss after trauma + why medicine feels helpless; introduce MB as the twist 4:01–5:57 — The study: 2025 rat model, what they tested and why MB fits the Energy Code framework 6:11–10:52 — Mechanism and injury cascade: optic canal choke point → swelling → ischemia → secondary degeneration + “cellular riot” 11:07–14:45 — Incidence, current options (steroids/surgery/observation), and the golden window 15:15–20:55 — Why MB: WHO essential medicine, mitochondrial bypass + iNOS/NO “poison valve” control 21:34–24:49 — Methods: optic nerve crush model, groups, dosing (2 mg/kg), timing (0–24h dosing), 21-day follow-up 25:02–31:35 — Results: ERG recovery (B-wave, OPs) + PHNR “complete preservation” of RGC function 32:04–35:17 — Stress testing (pattern ERG) + histology cell counts confirm structure matches function 35:19–38:48 — Human relevance + practicality: animal-to-human caution, but shared mechanisms; preparedness framing + close/CTA - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

We all know the common saying: “the mitochondria is the powerhouse of the cell.” But this Deep Dive flips that idea on its head. Instead of a simple battery, mitochondria behave like a second genetic system with its own DNA and its own “software layer” of control. Using a brand-new January 2026 review on mitochondrial epigenetic mechanisms in cancer by authors from University of Pisa, we explore how tumors hack mitochondrial methylation, DNA packaging, and non-coding RNAsto either floor the gas (energy production for rapid growth) or slam the brakes (metabolic dormancy for survival and metastasis). Then it gets even stranger: mitochondria can send RNA and metabolites that influence the nucleus, while the nucleus sends enzymes and RNAs back into mitochondria—creating a two-way power struggle cancer exploits. The big takeaway: cancer isn’t only a “mutation problem.” It’s also a reprogramming problem, which opens new doors for diagnostics and therapies designed to target the mitochondrial “operating system” directly. - Article Discussed in Episode: Mitochondrial epigenetic mechanisms in cancer: an updated overview - Key Quotes From Dr. Mike: “What if the powerhouse isn’t just a battery… it’s actually more like an alien spacecraft docked inside us, running its own separate operating system.” “Think of the DNA sequence as your computer hardware. Epigenetics is the software.” “Cancer is when that symbiosis turns into a power struggle.” “Cancer has figured out how to hack it." “Maybe, just maybe, the key to curing cancer isn’t just poisoning the cell, it’s about restoring that ancient peace treaty.” - Key points The “powerhouse” metaphor is incomplete: mitochondria act like a semi-independent system with a second genome and complex regulation. Mitochondrial DNA is small but vital (circular, bacterial-like), supporting the idea of an endosymbiotic origin. The review focuses on epigenetics: not changing DNA letters, but changing how genes are read via methylation “switches.” A long-running debate is framed as resolved: mitochondrial DNA can be methylated by enzymes that enter mitochondria, allowing gene silencing similar to the nucleus. Mitochondria also regulate access to their DNA through packaging proteins (a “tape/dimmer switch” controlling expression and energy output). Gas pedal: hypomethylation in key control regions (like the D-loop) to ramp up output for growth. Brake: hypermethylation to suppress replication and shift toward dormancy during hostile transitions (like metastasis). Cancer uses two strategies depending on context: Non-coding RNAs become “regulatory managers”: sense/antisense balance can be disrupted so tumors lose “stop signals,” and restoring the “good twin” can trigger selective tumor cell death in models. The future direction is precision oncology: using stable mitochondrial methylation/RNA signatures for screening (blood/urine signals) and designing therapies that specifically target mitochondrial epigenetic machinery. - Episode timeline 0:19 — Intro sting + the “powerhouse of the cell” meme setup 0:55 — Reframe: mitochondria as an “operating system” that cancer can hack 1:35 — The January 2026 review + mission: understand “mitoepigenetics” 2:13 — The “second genome”: mtDNA basics + endosymbiotic origin 3:26 — Epigenetics explained: software vs hardware; methylation as gene switches 4:40 — Debate resolved: mtDNA methylation exists; enzymes can tag/silence mtDNA 5:02 — mtDNA packaging (TFAM “tape”) + the mitochondrial “dimmer switch” idea 5:57 — Cancer’s two modes: gas vs brake strategies 6:14 — Gas pedal example: D-loop hypomethylation → increased output for growth 7:23 — Brake example: hypermethylation → reduced mitochondria + metabolic dormancy (metastasis survival) 8:40 — Drug resistance angle: methylation changes that help cells evade death triggers 9:41 — Non-coding RNAs: sense vs antisense “RNA twins” and the loss of brakes 11:26 — Viral hacking example: HPV-style mitochondrial reprogramming framing 12:30 — Therapeutic concept: reintroducing the “good twin” → selective apoptosis in models 13:25 — Circular RNAs and micro-RNAs: stable signals; cancer-type-specific roles 16:25 — Mitonuclear crosstalk: two-way signaling; mitochondria can influence nuclear epigenetics 18:55 — What this enables: diagnostics (blood/urine), mito-targeted therapies, gene-editing concepts 20:33 — Big metaphor: restoring the “peace treaty” (symbiosis) vs hacking - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

In this The Energy Code Deep Dive, we start with a topic that sounds like a prank: piglets + taurine. But it turns into a surprisingly universal lesson about how gut damage happens and how recovery actually works. We walk through research using piglets as a model for intestinal injury caused by DON (deoxynivalenol), a Fusarium mold toxin commonly found in grain contamination. DON doesn’t just irritate the gut. It collapses the mucus barrier(goblet cells and MUC2), breaks tight junction “zippers” (ZO2, occludin, claudin), and triggers apoptosis (BAX up, caspase-3 up, BCL-2 down). Underneath it all is the real root: mitochondrial failure—swollen, damaged cristae, and ATP levels dropping. Then comes the twist: taurine doesn’t “patch the wall.” It restores the power, revives mitochondrial function (and antioxidant defenses like SOD2), and appears to reactivate the PGC-1 → NRF1/NRF2 axis—the factory-manager-and-foremen system that turns the repair program back on. The big takeaway: many “structural” problems may secretly be energy problems. - Article Discussed in Episode: Taurine ameliorates deoxynivalenol-induced intestinal injury in piglets: Restoration of mitochondrial function linked to the PGC1α-NRF1/2 axis - Key Quotes From Dr. Mike: “We’re trying to fix the cracks in the wall, but maybe we should be checking the fuse box in the basement.” “If mitochondria are like little power plants, mitophagy is like the maintenance crew that removes broken generators before they start smoking up the whole city.” “In the DON toxin group… the mitochondria aren’t just stressed. They’re swollen… the cristae are broken.” “Taurine didn’t fix the machines itself. It walked into the office and woke up the manager.” “Taurine just flipped the breaker back on.” - Key points Piglets are the model; the biology is the message—the episode uses the gut as a window into a universal cellular fight. DON (a Fusarium mycotoxin) acts like a gut saboteur: it doesn’t just inflame tissue, it disrupts the cell’s energy system. The first visible hit is the mucus barrier: goblet cells drop, MUC2 production falls, and the “moat around the castle” drains. The next hit is the tight junction barrier: ZO2/occludin/claudin markers fall—your intestinal “zipper” loses teeth, turning into a literal leak. Cells enter a panic state and trigger apoptosis: BAX/caspase-3 rise, BCL-2 drops—a death order goes out. The root cause is mitochondrial dysfunction: swollen mitochondria, damaged cristae, ATP depletion—the factory loses power. Taurine reverses the cascade: preserves goblet cells, restores tight junctions, reduces apoptosis signals, and improves mitochondrial function + antioxidant support (SOD2). Mechanistic “why”: taurine appears to reactivate the PGC-1 / NRF1 / NRF2 repair axis, essentially waking up the mitochondrial rebuild program—energy first, structure second. - Episode timeline 00:00–01:20 — Cold open: piglets + taurine + why this isn’t an energy drink episode 01:20–03:00 — The villain: DON mycotoxin (Fusarium on grains) + why the model matters 03:00–05:00 — Barrier layer #1: goblet cells + MUC2 mucus “moat” collapses; taurine restores it 05:00–06:40 — Barrier layer #2: tight junction “zipper” (ZO2/occludin/claudin) breaks; taurine reseals it 06:40–08:40 — Cellular crime scene: apoptosis lights up (TUNEL), BAX/caspase-3 up, BCL-2 down; taurine flips the death balance 08:40–10:50 — The engine room: mitochondria swell, cristae break, ATP drops; taurine restores structure + ATP + SOD2 10:50–13:10 — The master switch: PGC-1 → NRF1/NRF2 axis as manager/foremen/blueprints; DON silences it, taurine reactivates it 13:10–15:00 — Big takeaway: many conditions may be “energy problems” first; closing reflections + sign-off - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive, we review a real-world, high-stakes study that sounds like sci-fi: using methylene blue + a specific wavelength of light to kill antibiotic-resistant bacteria. The clinical backdrop is pediatric perforated appendicitis, where bacteria can leak into the abdomen and lead to serious infections, long hospital stays, and heavy IV antibiotic use. The paper tests photodynamic therapy (PDT): add a light-sensitive dye (methylene blue), shine 665nm light, and generate reactive oxygen species that inflict broad oxidative damage on microbes—often regardless of classic antibiotic resistance mechanisms. The results are striking for several major pathogens, with huge log reductions for E. coli and Streptococcus anginosus group, and more variable results for Pseudomonas aeruginosa. We also keep it grounded: it’s in vitro, not yet a clinical protocol, and it didn’t test everything you’d want (biofilms, polymicrobial mixtures, anaerobes). But as a proof-of-concept, it’s a strong argument that light can be a precise medical tool—when parameters are engineered, not guessed. - Article Discussed in Episode: Photodynamic therapy with methylene blue effectively kills antibiotic resistant bacteria from pediatric patients with perforated appendicitis - Key Quotes From Dr. Mike: “Photodynamic therapy doesn’t rely on the same mechanisms as antibiotics, so it can work even when bacteria are resistant.” “You take a dye that’s light sensitive… add it to the bacteria, then you shine a specific wavelength of light.” “Methylene blue is the match, the light is the strike.” “A 6-log reduction is a millionfold reduction… basically a wipeout in this kind of lab setup.” “The key takeaway is resistance didn’t protect bacteria from this approach in most cases.” - Key points The study targets a big clinical problem: perforated appendicitis in kids → intra-abdominal infection risk, long hospitalization, heavy antibiotic exposure. The intervention is photodynamic therapy (PDT): methylene blue + 665nm light → reactive oxygen species that damage bacteria. PDT doesn’t rely on standard antibiotic mechanisms, so it can work even when bacteria are antibiotic-resistant. Methods: bacteria isolated from peritoneal fluid samples (30 patients) and tested under 4 conditions: control, dye-only, light-only, dye+light. Parameters matter: 665nm laser via fiber optic; low fluence rate (4 mW/cm²), total fluence 7.2 J/cm², 30 min; methylene blue 300 mcg/mL. Most prevalent organisms included E. coli, Strep anginosus group, Bacteroides fragilis, Pseudomonas aeruginosa; polymicrobial infections were common. Results: ~5.86–5.91 log₁₀ reductions for E. coli and Strep anginosus group (massive kill); Pseudomonas showed smaller, variable reductions (~2.23 log₁₀). Limitations: in vitro, planktonic monocultures (not biofilms/mixed communities), anaerobes not tested in PDT setup, and parameter optimization still needed—yet the proof-of-concept is very promising for a localized surgical adjunct. - Episode timeline 0:19 — Intro sting + welcome back 0:32 — Topic hook: methylene blue + light vs antibiotic-resistant bacteria 1:06 — Clinical context: pediatric perforated appendicitis → infections, IV antibiotics, long stays 1:49 — PDT explained simply (dye + light → ROS; works beyond antibiotic resistance) 2:39 — Study design: 30 patient samples; isolate bacteria; 4 test conditions 3:13 — Technical parameters: 665nm laser/fiber optics; dosing details; why specs matter 3:50 — What bacteria were found; polymicrobial reality + resistance common 4:36 — Results: major kills for E. coli & Strep; Pseudomonas more variable 5:13 — Quick “log reduction” translation for normal humans 6:16 — Resistant vs susceptible strains: resistance didn’t protect (most cases) 6:54 — Big vision: localized surgical adjunct via laparoscopic illumination 7:24 — Limitations: in vitro, monocultures, no biofilms/mixed species, anaerobes not tested, optimization needed 8:19 — BioLight tie-in (light as precise tool; don’t wing it; specs matter) 9:29 — One-sentence takeaway - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

In this Energy Code Deep Dive, Dr. Mike Belkowski and moderator Don Bailey break down a 2024 systematic review, “Targeting Aging With Urolithin A in Humans," that focuses on human supplementation studies, not “eat pomegranate and hope.” You’ll learn what Urolithin A is (and why your gut bacteria can make results wildly inconsistent), why it’s tied to “geroprotection,” and what the clinical evidence actually supports so far: dose-dependent anti-inflammatory signals, changes in mitochondrial/autophagy gene markers, and some improvements in strength/endurance — with a reality check on what didn’t move (ATP max, broad physical function, microbiome composition, body comp, cardiovascular markers in short windows). Bottom line: promising, practical, but still early. - Article Discussed in Episode: Targeting aging with urolithin A in humans: A systematic review - Key Quotes From Dr. Mike & Don: “It’s like giving two people the same coffee beans, but one of them doesn’t own a coffee grinder!” "It may be improving the ‘quality control and efficiency settings’ more than raw peak horsepower.“ “So it’s like tuning the car so it runs smoother; not necessarily making the top speed higher.” "It’s not a ‘lose 20 pounds and become a triathlete’ pill.” - Key points Urolithin A is a gut-derived metabolite from ellagic acid foods (pomegranate, walnuts, berries), but many people don’t convert well. So food intake ≠ reliable levels. Supplementation “skips the gut lottery” and produces higher, more consistent plasma levels than food sources. The systematic review included 5 human studies / 250 healthy participants with 10–1000 mg/day for 28 days to 4 months. Biggest consistent theme: dose-dependent anti-inflammatory effects (some markers improve more at 1000 mg/day over 4 months). Mitochondria story is nuanced: it may improve gene expression signatures related to mitochondrial activity, autophagy, and fatty-acid oxidation—more “quality control” than peak power. What it didn’t reliably do: increase maximal ATP production, consistently boost biogenesis/dynamics markers, change gut microbiota composition, or meaningfully affect body metrics/cardiovascular outcomes in short trials. Muscle outcomes: some gains in specific strength/endurance measures (e.g., torque metrics; certain fatigue tests), but not universal (e.g., handgrip and broad function didn’t consistently improve). Safety in these studies looked clean (no serious adverse events attributed), but the overall conclusion remains: promising—but the human aging evidence is still young and needs longer/larger trials. - Episode timeline 0:27 — Welcome + urolithin A is trending + episode topic 0:45 — Don’s moderator frame: “does it work / worth it?” 1:04 — Paper ID (2024 systematic review; human supplementation) 1:25 — What urolithin A is + “gut lottery” 2:02 — Why supplement (higher/consistent levels vs food) 2:24 — Why it matters: mitophagy / healthier aging angle 3:05 — What’s included (5 studies, 250 people; 10–1000 mg; 28d–4mo) 3:34 — What improved (inflammation signals, gene markers, some strength/endurance) 4:06 — What didn’t (max ATP, microbiome, broad health/body metrics) 7:02 — Dosing/PK basics (peak ~6h; half-life ~17–22h; plateau ~7d) 7:40 — Safety summary 8:06 — Practical take + “promising but early” conclusion - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Welcome to the first Energy Code Deep Dive—daily research reviews translated into real life. Dr. Mike Belkowski and co-host Don Bailey break down a brand-new (Jan 3, 2026) pilot study on transcranial photobiomodulation (tPBM) for chemobrain (cancer-related cognitive impairment). We define what chemobrain actually feels like, why there aren’t many proven treatments, and why researchers are exploring 810nm brain-directed light + an intranasal component to support mitochondrial energy (cytochrome c oxidase/ATP), inflammation balance, blood flow, and repair signaling. Then we walk through the real-world clinical cohort (31 women), the protocol (weekly sessions, ~20 minutes, 10+ sessions), and the eye-opening outcomes: 29/31 improved, average cognitive scores rose dramatically, and a meaningful percentage normalized. We also keep it honest—small sample, retrospective design, no control group—so you know what’s promising now and what still needs randomized trials. - Article Discussed in Episode: Transcranial photobiomodulation for the treatment of chemobrain: new perspectives from a pilot study - Key Quotes From Dr. Mike: “It’s like your brain’s running 30 browser tabs and somebody started a video call in the background.” “Think of it like giving your brain cells a more efficient ‘charge cycle,’ not by caffeine, but by improving cellular energy production.” “This is why device specs aren’t nerd trivia. They’re the difference between a protocol and a placebo.” “This pilot study suggests that transcranial photobiomodulation may meaningfully improve chemobrain symptoms… but we still need larger controlled trials.” - Key points Chemobrain is real: attention, processing speed, verbal fluency, executive function — often lingering for years and impacting daily life. The study reviewed a Jan 3, 2026 pilot exploring tPBM as a potential supportive treatment when proven options are limited. Mechanism focus: light targets mitochondrial function (cytochrome c oxidase → ATP), with downstream effects on inflammation, blood flow, and repair signaling. Cohort: 31 women, average age ~52, post-chemo cognitive impairment; cognition tracked via FACT-Cog. Protocol: 810nm transcranial + intranasal, ~20 min/session, weekly, 10+ sessions; some also used whole-body PBM. Why 810nm: penetration matters; modeling suggests near-optimal depth to reach cortical targets; intranasal may help access harder-to-reach regions. Results were striking: average score improved from ~63 to ~101; 29/31 improved; ~29% normalized into typical range. Limitations & takeaway: retrospective + no control group (can’t rule out time/placebo), but the effect size supports moving toward larger randomized trials and reinforces that parameters/device specs matter. - Episode timeline 00:00 – Welcome to the first Energy Code Deep Dive + Don’s role as the “question-asker” 01:30 – What is chemobrain (symptoms + what it feels like day-to-day) 04:00 – Why treatment options are limited (the “brutal part”) 05:30 – What transcranial photobiomodulation is (plain-English translation) 07:30 – Biology: cytochrome c oxidase, ATP, inflammation, blood flow, repair signaling 10:00 – Study design + who they studied (31 women, France, post-chemo, FACT-Cog) 12:30 – Real-life impacts (reading, admin work, conversations, driving, fatigue, sleep) 14:30 – Protocol details (810nm, intranasal, weekly 20 min, 10+ sessions, some whole-body) 17:00 – Why 810nm + why intranasal (penetration + access) 19:00 – Results (63 → 101, 29/31 improved, ~29% normalized, QoL changes) 21:30 – Mood/anxiety/depression findings + interpretation 23:00 – Mechanisms: chemo injury pathways vs PBM supportive pathways 25:30 – Limitations (small sample, retrospective, no control, can’t split brain vs whole-body) 27:30 – Safety notes + “what do I do with this?” (talk to clinician; parameters matter) 29:00 – One-sentence takeaway + close (“Protect your energy / mitochondria”) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

Neurodegeneration can feel like an unstoppable train, where treatment is often about managing symptoms instead of fixing what’s breaking upstream. In this episode of The Energy Code, Dr. Mike Belkowski and co-host Don Bailey unpack a 2025 review on mitochondrial dysfunction as a common thread across major neurodegenerative diseases and why this “cellular infrastructure problem” may be the leverage point researchers are finally targeting. You’ll get clear, memorable analogies for how energy production fails (oxidative phosphorylation), why Complex I dysfunction shows up so often in Parkinson’s, and why ROS isn’t “bad” until it becomes a wildfire. From there, they walk through mitochondrial quality control (fission, fusion, and mitophagy) plus the underrated issue of mitochondrial transport in long neurons. Finally, we break down what’s being explored right now: mitochondria-targeted antioxidants, metabolic interventions, photobiomodulation, biogenesis strategies (PGC-1α), and emerging frontiers like mitochondrial transplantation and gene editing—with a grounded take on what’s promising vs. what’s still early. - Key Points Neurodegeneration is increasingly being viewed as an upstream mitochondrial dysfunction problem and not just a symptom-management problem. The brain is an extreme energy consumer, so neurons are uniquely vulnerable when ATP production drops. Oxidative phosphorylation failure reduces cellular power and sets the stage for degeneration. In Parkinson’s, Complex I impairment is a recurring theme → less ATP + more oxidative stress. ROS isn’t inherently bad — it’s signaling vs “wildfire” oxidative stress when defenses get overwhelmed. Mitochondrial “quality control” (fission, fusion, mitophagy) is central; breakdown accelerates damage. Neurons depend on mitochondrial transport down long axons; transport failure can starve synapses first. Emerging interventions include mitochondria-targeted antioxidants, biogenesis/repair pathways, and mitochondria-relevant trials (including photobiomodulation) promising, but still evolving. - Key Quotes From Dr. Mike “Fission is like splitting dough into separate pizzas. Too much fission is like cutting everything into tiny crumbs.” “Too little fission is like refusing to separate the burnt part… it ruins the whole batch.” “This is the recycling program… Tag it, bag it, take it out.” “PGC-1 alpha is like the head contractor for building new power plants.” “If demand doubles, you can’t keep running on the same number of servers… you need more infrastructure.” - Article Referenced in Episode: Mitochondrial-based therapies for neurodegenerative diseases: a review of the current literature - Episode Timeline 00:00 — Cold open + show intro (“The Energy Code” mission / mitochondrial matrix) 00:45 — The “unstoppable train” problem: symptoms vs upstream causes 02:00 — Why mitochondria matter in the brain (energy hog / “city that never sleeps”) 04:00 — Quick definitions: Alzheimer’s vs Parkinson’s vs ALS 05:30 — Oxidative phosphorylation explained (dam/turbine analogy) 08:00 — Parkinson’s spotlight: Complex I disruption + downstream ROS 10:00 — ROS with nuance: signaling vs oxidative stress + antioxidant balance 12:30 — The quality-control trio: fission, fusion, mitophagy (pizza + recycling analogies) 15:30 — Mitochondrial transport in neurons (train tracks: kinesin/dynein) 17:00 — Therapy bucket #1: mitochondria-targeted antioxidants (why targeting matters) 18:30 — “Is it being tested?” clinical trial examples across AD/PD/ALS 20:30 — Photobiomodulation: keep it grounded (flashlight/battery analogy) 22:30 — Biogenesis: PGC-1α + AMPK/SIRT1 + exercise mimetics 25:00 — Frontiers: transplantation, gene therapy/CRISPR, ethics/regulation 28:30 — Five takeaways + closing call-to-action (subscribe/review/share) - Dr. Mike's #1 recommendations: Deuterium depleted water: Litewater (code: DRMIKE) EMF-mitigating products: Somavedic (code: BIOLIGHT) Blue light blocking glasses: Ra Optics (code: BIOLIGHT) Grounding products: Earthing.com - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

In this episode of The Energy Code, Dr. Mike delivers a wide-ranging solo deep dive into some of the most compelling mitochondrial and longevity research published over the last several months. Moving beyond hype and “magic bullet” thinking, this episode reframes aging, energy, and resilience through the lens of systems biology — where mitochondria, immune signaling, light, stress, and the microbiome all converge. Dr. Mike walks listeners through five recent peer-reviewed studies spanning immune rejuvenation, photobiomodulation, red light–driven lifespan extension, methylene blue–mediated neuroprotection, and microbiome-dependent longevity metabolites. Across each paper, a central theme emerges: health is not about forcing outcomes, but about restoring signaling, redox balance, and mitochondrial adaptability. This episode highlights why fatigue is often protective, why antioxidants can backfire, how light functions as biological information, and why personalized bioenergetics — not one-size-fits-all protocols — represents the future of longevity medicine. Key Points Longevity science has shifted from speculation to mechanism-driven biology Immune aging is driven by mitochondrial dysfunction and cellular senescence Red and near-infrared light act as hormetic mitochondrial stressors Proper photobiomodulation follows a biphasic dose response Early red light exposure can extend lifespan and healthspan in model organisms Methylene blue supports mitochondrial redox balance and brain resilience Fatigue is often a protective mitochondrial signal, not an energy deficit Antioxidants can blunt beneficial mitochondrial adaptation The gut microbiome determines urolithin A and B production Longevity interventions are inherently n=1 and ecosystem-dependent Key Quotes “Fatigue is often a protective signal — not a lack of energy.” “Light becomes information, food becomes signaling, and molecules become tools.” “Mitochondrial medicine isn’t the future — it’s now.” “Longevity isn’t about magic bullets. It’s about systems biology.” Key Moments 00:00 – 05:25 Introduction, 2026 vision, and expansion of Energy Code Deep Dives 05:26 – 14:18 Urolithin A & immune rejuvenation — mitochondrial metabolism and immunosenescence 14:29 – 21:57 Photobiomodulation, biphasic dosing, and mitochondrial signaling 21:57 – 26:35 Red light exposure, AMPK activation, lifespan and healthspan extension 27:01 – 30:36 Methylene blue, neuroinflammation, blood–brain barrier protection 31:06 – 34:44 Microbiome-dependent urolithin production and personalized longevity 34:45 – 38:02 Systems biology, decentralized health, and closing reflections Books & References Mentioned Nature Aging — Urolithin A & immune decline Scientific Reports — Photobiomodulation & mitochondrial signaling Aging and Disease — Red light–driven lifespan extension Scientific Reports — Methylene blue & neuroprotection Gut microbiome enzymatic mapping of urolithin production - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

In this week’s episode of The Energy Code, Dr. Mike Belkowski is joined by co-host Don Bailey and special guest Jackie Jolie, quantum biology practitioner and founder of AnimaSol (formerly EquiSol). Together, they explore how light — particularly red and near-infrared wavelengths — shapes mitochondrial health, recovery, longevity, and disease prevention in both humans and animals. Jackie shares her personal health journey, including recovering from Lyme disease by radically changing her light environment, circadian rhythms, and mitochondrial signaling. What began as self-experimentation evolved into a mission: restoring animals’ health through light after witnessing skyrocketing rates of obesity, arthritis, anxiety, and chronic disease in modern pets. The conversation dives deep into photobiomodulation, redox potential, parasympathetic nervous system activation, and why light should be viewed as a daily nutrient, not just a therapy. Jackie explains the science behind full-body red light therapy for animals, why contact-based LED devices outperform high-powered lasers, and how light restores systemic balance rather than merely treating isolated injuries. Listeners will hear powerful real-world case studies — including paralyzed dogs walking again, rapid tendon healing in performance horses, reduced anxiety and aggression in shelter dogs, and metabolic improvements in animals suffering from obesity and insulin dysfunction. Throughout the episode, a central theme emerges: modern disease is a mismatch between biology and environment — and restoring light exposure may be the missing foundation for healing. 🔑 Key Points Lyme disease susceptibility is strongly influenced by mitochondrial redox potential and light environment Light, water, and magnetism form the foundation of quantum biology Red and near-infrared light directly support mitochondrial function and ATP production Modern indoor lifestyles create a severe light deficiency in humans and pets Red light therapy activates the parasympathetic nervous system (“rest and digest”) Full-body illumination produces systemic healing, not just localized effects LEDs can be safer and more practical than high-powered lasers for animals Anxiety, aggression, and behavioral issues often improve with light therapy Obesity and metabolic dysfunction in pets mirror human disease trends Light should be treated as a daily supplement, not a last-resort therapy 💬 Key Quotes from Jackie Jolie “I didn’t have a good light life — and my mitochondria couldn’t overcome the tick bite.” “The most vital nutrient our pets are deficient in is light.” “Red light therapy taps into the parasympathetic nervous system — animals literally melt.” “If light created the problem, light can also be the solution.” “Nature is the OG healer — nothing replaces the sun.” ⏱️ Key Moments 00:00 – 06:58 Jackie’s Lyme disease recovery & discovering quantum biology 06:58 – 09:26 Circadian rhythm repair, redox potential, and light as medicine 09:26 – 13:09 Why contact-based red light works through fur and skin 16:29 – 19:32 Light deficiency as a modern epidemic in pets 30:28 – 35:38 Powerful healing case studies (paralysis, anxiety, arthritis) 35:38 – 38:24 Metabolic disease, obesity, and insulin dysfunction in animals 47:02 – 49:56 The future of red light therapy for pets, performance animals & beyond Where to Learn More From & About Jackie:AnimaSol website AnimaSol IGAnimaSol Facebook - 🚨 SPECIAL OFFER! 🚨 We've introduced a bevy of new anti-aging skincare products the last couple of months, most recently the Mystic nano-mister and the Blue Mist (made to be paired together)... For the next week, save 20% on any of the below skincare products. This is a great time to stock up on gifts for family, friends and (of course) yourself! Save 20% on the BioMinerals Mist, Platinum Mist, the Mystic and Blue MistDiscount code: skincare20Expires 1/22, midnight PST *For Mist products, must choose "Single" option and increase to desired amount. Cannot use code on two-, four- or ten-packs. Shop BioLight Skincare products! - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Connect with Jackie: https://www.animasol.life/pages/about - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

This is the #1 episode from 2025. Enjoy! - Methylene blue has been going viral recently and not always for the right reasons.... or so their claimers make it seem. The most recent example of this is Dr. Paul Saladino's video he posted on social media he states that methylene blue actually "decreases ATP production" amongst other rationales for why people should not be consuming this mitochondrial-boosting agent. In the beginning of todays episode, I thoroughly and clearly state my thoughts on Dr. Saladino's hot take.The second topic entails a prelude about deuterium: what it is, how it impacts our mitochondrial function and some strategies to help mitigate its negative effects. We first discuss deuterium, because the research article we cover today is about taurine and its implications for helping the body produce deuterium-depleted water and/or helping the body decrease its deuterium content altogether. This not only has implications for overall health, but countless diseases and cancers as well. If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :)As always, light up your health! - Key points: •00:25 – Upcoming Health Optimization Summit and new BioLight product •02:20 – Responding to Paul Saladino’s methylene blue criticism •04:14 – Why understanding mitochondria is critical for health •05:54 – Mitochondrial dysfunction behind 80% of modern diseases •08:37 – Clarifying research on methylene blue and ATP production •10:16 – Layman summary of study supporting methylene blue benefits •12:26 – Introducing the BioLight Cocoon for full-body therapy •15:03 – Methylene blue boosts energy, especially with poor mitochondria •16:46 – Addressing methylene blue brain staining concerns •19:03 – Importance of methylene blue quality and detox pathways •20:38 – The problem with click-driven health influencers •21:40 – Encouraging fact-checking and personal research •23:17 – What deuterium is and why it harms mitochondria •28:09 – Common sources of deuterium in food and water •33:08 – How to lower deuterium through diet and habits •35:17 – Taurine’s powerful impact on mitochondrial function •39:30 – Taurine helps reduce oxidative stress and improve energy •41:23 – Taurine’s role in gut health and deuterium balance •46:51 – Study shows taurine protects mitochondria from deuterium •50:39 – Taurine and deuterium-depleted water for cancer support •52:12 – Why taurine is in BioBlue capsules •54:17 – Final thoughts and upcoming events - Article referenced in episode: Taurine prevents mitochondrial dysfunction and protects mitochondria from reactive oxygen species and deuterium toxicity - Save 25% when you Subscribe & Save to a BioBundle! For a BioBundle, you choose:1.) Any one BioBlue supplement(BioBlue, BioBlue (SR), BioBlue Leuco, BioBlue Calm, BioBlue Capsules or BioBlue Leuco Capsules)2.) Any one BioC60 supplement(Regular or Concentrated) The BioBundle automatically saves you 15% on both of the supplements you choose.You save an additional 10% by choosing to Subscribe & Save to that BioBundle.The 25% savings is passed along for every monthly delivery of your BioBundle!No discount code necessary! Click here to check out The BioBundle - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

This is the #2 episode from 2025. Enjoy! - In this inaugural episode of The Energy Code, Dr. Mike Belkowski officially launches the podcast’s next evolution—expanding beyond red light therapy into a broader framework of mitochondrial health, performance, and longevity. Dr. Mike explains why The Red Light Report is rebranding and how this new chapter will embrace the Mitochondrial Matrix—a flexible, expanding framework of modalities, molecules, and lifestyle strategies designed to upgrade your cellular energy system. At the heart of this episode is a deep dive into urolithin A and B, two emerging powerhouse compounds shown to activate mitophagy, optimize mitochondrial efficiency, support muscle strength, and even protect against neurodegeneration and osteoarthritis. You’ll learn how these metabolites—found in pomegranates but best delivered in supplement form—fit into the mitochondrial matrix, and why they may become a cornerstone for anti-aging and vitality. Finally, Dr. Mike introduces BioLithin, BioLight’s brand-new supplement that combines high-purity urolithin A, urolithin B, and taurine from pomegranate peel for unmatched mitochondrial support. Expect both a big-picture reframe of the podcast’s mission and practical insights into how to leverage cutting-edge science to keep your mitochondria young, strong, and resilient. Key Topics Covered: Why The Red Light Report is evolving into The Energy Code The shift from the Mitochondrial Triad to the Mitochondrial Matrix What mitophagy is and why it’s critical for health and longevity How urolithin A and B enhance mitochondrial function, strength, and resilience The latest research on urolithins for anti-aging, cancer, cognition, and anxiety Why supplement sourcing (pomegranate peel vs. juice) matters for efficacy The launch of BioLithin: the first supplement to combine urolithin A, urolithin B, and taurine Key Quotes from Dr. Mike: “Urolithin A doesn’t hype your mitochondria—it housekeeps them.” “Strength loss is one of the biggest contributors to aging. If urolithin B helps maintain muscle, that’s a game-changer.” “Instead of chasing the next biohack, we’re building the Mitochondrial Matrix—a foundation you can layer for compounding benefits.” “With the right tools, your body knows how to heal. All we’re doing is fueling the mitochondria to do their job.” Episode Timeline: 00:00:00 – Welcome to The Energy Code: why the rebrand 00:07:00 – From the Mitochondrial Triad to the Mitochondrial Matrix 00:14:00 – Mitophagy explained: the “garbage cleanup” of your cells 00:19:00 – Urolithin A: mitochondrial quality control & endurance benefits 00:27:00 – Urolithin B: anabolic potential, strength, and joint protection 00:37:00 – Emerging research: cancer, cognition, and anxiety applications 00:56:00 – BioListen unveiled: urolithin A + B + taurine supplement 01:10:00 – How to integrate BioListen into your regimen 01:13:00 – Closing thoughts: raising your cellular voltage for vitality Resources & Articles Referenced: Evaluation and Comparison of the Anti-Metastatic Effects of Urolithin A and B in Esophageal Cancer Cells (2025)​ Urolithin A Protects Against Domoic Acid-Induced Cognitive Deficits via Mitochondrial Biogenesis (2025)​ Urolithin A Abolishes High Anxiety and Restores Mitochondrial Signatures in the Brain (2025)​ Urolithin B Reduces Cartilage Degeneration and Alleviates Osteoarthritis (2024) Special Offer: ⚡️ NEW PRODUCT FROM BIOLIGHT!! ⚡️Introducing.... BioLithin!!! Your cells are powered by mitochondria — the tiny engines that produce the energy you need to move, think, and thrive. As we age, mitochondrial efficiency naturally declines, which can affect everything from vitality and stamina to how quickly you recover. Unlike most supplements that focus only on Urolithin A, BioLithin pairs Urolithin A and Urolithin B with taurine, creating a more comprehensive approach to mitochondrial optimization. This three-pronged formula is designed for individuals seeking to maximize their energy, longevity, and daily performance at the cellular level. Why Choose BioLithin? Dual-action urolithins (A + B) from pomegranate peel Synergistic taurine for mitochondrial resilience Clean, effective, and science-driven formulation Made for biohackers, longevity enthusiasts, and anyone looking to sustain their cellular energy over time Dr. Mike’s Top Recommendations: Water: Water & Wellness Grounding: Earthing.com EMF mitigation: Somavedic Blue light-blocking glasses: RA Optics Stay Connected: Instagram: @dr.mikebelkowski LinkedIn: Dr. Mike Belkowski BioLight: Website | Instagram | Facebook

This is the #3 episode from 2025. Enjoy! - In this deep-dive episode of The Red Light Report, Dr. Mike Belkowski takes you beyond the basics to explore why mitochondrial function is the true driver of health—and disease. After contrasting centralized vs. decentralized health paradigms, he reveals the root causes and systemic effects of mitochondrial dysfunction, using vivid analogies like “rocks in a river” to explain electron leakage and oxidative stress. From there, Mike unpacks the Six Pillars of Mitochondrial Health: 1. Energy Production – ATP synthesis & structured “EZ” water batteries 2. Biogenesis – Growing new mitochondria via PGC-1α, NRF1/2, TFAM 3. Mitophagy – Recycling damaged mitochondria through PINK1/Parkin 4. Fusion/Fission – Dynamic balancing of mitochondrial networks 5. Oxidative Stress Protection – Internal and supplemental antioxidants 6. Light Interaction – How red/NIR light supercharges bioenergetics Along the way, learn why methylene blue and red light therapy are synergistic brain- and mitochondria-boosters, why proper breathing and oxygen availability are non-negotiable, and how lifestyle tactics—from grounding to sun exposure—tie back to cellular power. Mike closes with a sneak peek at an upcoming all-in-one mitochondrial optimization product designed to tackle all six pillars at once. If you found the information in today's episode particularly interesting and/or compelling, please share it with a family member, friend, colleague and/or anyone that you think could benefit and be illuminated by this knowledge. Sharing is caring :) As always, light up your health! - 00:00 – Introduction: Mitochondrial Health & Podcast Focus 02:14 – Centralized vs. Decentralized Health Paradigms 03:43 – Mitochondrial Dysfunction: Causes and Effects 05:11 – Six Pillars of Mitochondrial Function Overview 07:39 – Pillar 1: Energy Production (ATP & EZ Water) 09:02 – Methylene Blue: Brain Boost + Mitochondrial Synergy 19:15 – Root Causes of Disease via Mitochondrial Dysfunction 20:11 – Electron Transport Chain Analogy (Rocks in a River) 26:47 – Importance of Breathing & Oxygen for Mitochondria 28:19 – Pillar 2: Mitochondrial Biogenesis 33:25 – Pillar 3: Mitophagy (Mitochondrial Cleanup) 39:24 – Pillar 4: Mitochondrial Fusion & Fission 43:08 – Pillar 5: Free Radical & Oxidative Stress Protection 48:11 – Antioxidants: Internal & External Defenses 52:18 – Pillar 6: Light’s Impact on Mitochondria 58:29 – Light = Battery for Cells: Red/NIR Light & EZ Water 59:20 – Recap: The Six Pillars of Mitochondrial Health 01:00:17 – Tease for New Product: Optimizing All Six Pillars 01:02:13 – Final Thoughts: Pursuing the Mitochondrial Fountain of Youth - Save 25% when you Subscribe & Save to a BioBundle! For a BioBundle, you choose:1.) Any one BioBlue supplement(BioBlue, BioBlue (SR), BioBlue Leuco, BioBlue Calm, BioBlue Capsules or BioBlue Leuco Capsules)2.) Any one BioC60 supplement(Regular or Concentrated) The BioBundle automatically saves you 15% on both of the supplements you choose.You save an additional 10% by choosing to Subscribe & Save to that BioBundle.The 25% savings is passed along for every monthly delivery of your BioBundle!No discount code necessary! Click here to check out The BioBundle - Dr. Mike's #1 recommendations: Water products: Water & Wellness Grounding products: Earthing.com EMF-mitigating products: Somavedic Blue light-blocking glasses: Ra Optics - Stay up-to-date on social media: Dr. Mike Belkowski: Instagram LinkedIn BioLight: Website Instagram YouTube Facebook

In this week’s episode of The Energy Code, Dr. Mike is joined by co-host Don Bailey for a wide-ranging, rapid-fire deep dive into the most misunderstood organelle in human health: the mitochondria. What starts as a discussion around a listener review of methylene blue and glucose control quickly expands into a sweeping exploration of energy, aging, fat loss, inflammation, hormones, stress, exercise, circadian biology, and recovery — all through a mitochondrial lens. Dr. Mike breaks down why early improvements in continuous glucose monitor (CGM) data can occur within days of mitochondrial optimization, even without direct effects on insulin secretion. He explains how methylene blue may enhance peripheral glucose disposal by improving mitochondrial electron flow, reducing oxidative stress, increasing ATP yield per unit of glucose, and restoring metabolic flexibility — offering a compelling bioenergetic framework for understanding blood sugar regulation beyond calories and insulin alone. The conversation then accelerates into a rapid-fire Q&A covering foundational mitochondrial concepts every listener should understand: why thin people can still be metabolically unhealthy, how mitochondrial dysfunction precedes visible disease, why fatigue is often a protective signal rather than a lack of ATP, and how chronic stress acts as a true mitochondrial toxin. Dr. Mike and Don also explore how mitochondria regulate fat burning, aging speed, inflammation, hormonal signaling, VO₂ max, exercise recovery, and even psychological motivation. Throughout the episode, Dr. Mike emphasizes a central theme: health is not about chasing symptoms — it’s about restoring mitochondrial quality, signaling, and efficiency. From red and near-infrared light’s direct interaction with cytochrome c oxidase, to why mitophagy matters more than simply making more mitochondria, to the dangers of excessive antioxidants blunting adaptation, this episode delivers a masterclass in mitochondrial medicine — practical, provocative, and immediately actionable. The episode closes with a candid discussion on decentralized health, emerging mitochondrial testing, vagus nerve stimulation, and why mitochondrial medicine isn’t some distant future concept — it’s already reshaping how we understand energy, longevity, and resilience. Key Points Mitochondrial optimization can improve CGM glucose readings within days via peripheral mechanisms. Methylene blue may enhance glucose disposal by improving mitochondrial electron transport and ATP efficiency. Thin individuals can still be metabolically unhealthy due to mitochondrial dysfunction. Fatigue is often a protective mitochondrial signal, not an ATP shortage. Chronic stress acts as a mitochondrial toxin, reducing energy output and metabolic flexibility. Fat burning only occurs when mitochondria can efficiently process energy. Mitophagy is more important than simply building new mitochondria. Red and near-infrared light directly stimulate mitochondrial respiration via cytochrome c oxidase. Exercise works because it forces mitochondrial adaptation — not because it burns calories. Excess antioxidants can blunt beneficial mitochondrial signaling. VO₂ max is a practical proxy for mitochondrial capacity. Circadian disruption damages mitochondria long before disease appears. Mitochondrial dysfunction almost always precedes symptoms of aging and disease. Key Quotes From Dr. Mike “Fatigue is often a protective signal — not a lack of energy.” “Fat burning only happens when mitochondria can efficiently process energy.” “It’s not just about making more mitochondria — it’s about cleaning up the damaged ones.” “Exercise works because it challenges the mitochondria to adapt.” “Mitochondrial medicine isn’t the future — it’s now.” Key Moments 00:00 – 03:09 Intro, holiday reflections, and listener review on methylene blue and CGM glucose improvements 03:10 – 10:48 Methylene Blue & Glucose Control — mechanisms, CGM changes, mitochondrial electron flow, ATP efficiency 10:48 – 16:39 Why mitochondrial health fixes multiple systems at once + aging, gut health, and oxygen balance 16:39 – 23:17 Thin but unhealthy, aging speed, fatigue signaling, inflammation, fat burning, mitophagy 23:17 – 28:14 Red light therapy, mitochondrial activation, exercise as a mitochondrial stimulus 28:14 – 34:57 Brain signaling, motivation, oxidative stress, antioxidants, dosage matters 34:57 – 41:07 Hormones, VO₂ max, circadian rhythm, mitochondrial DNA damage 41:07 – 49:06 Root causes of disease, decentralized health, corporate control of health narratives 49:06 – 56:08 Stress, EMFs, vagus nerve stimulation, parasympathetic recovery 56:08 – 01:06:45 Mitochondrial testing, exercise reframed, closing reflections on mitochondrial medicine Books & References from Episode The Life Machines — Daria Mochly-Rosen & Emmanuel Rosen Methylene Blue & Mitochondrial Bioenergetics Red & Near-Infrared Light Therapy Research Mitophagy & Aging VO₂ Max

In this week’s episode of The Energy Code, Dr. Mike explores one of the most eye-opening frontiers in modern biology: the mitochondrial roots of psychiatric disorders and cancer. Drawing from The Life Machines, he discusses research showing that mitochondrial dysfunction may drive anxiety and depression rather than simply correlate with them. Studies in animals demonstrate that altering mitochondrial fusion proteins like MFN2 can erase or induce anxiety-like behaviors, while human data links major depressive disorder to elevated mitochondrial DNA, impaired ATP production, and shortened telomeres. As psychiatrist Chris Palmer argues in the excerpt, mental illness may ultimately be a metabolic disorder of the brain—placing mitochondria at the center of emotional and cognitive health. Dr. Mike then shifts into a striking breakdown of how cancer hijacks mitochondrial biology to survive, evade immunity, and metastasize. From disabling programmed cell death to relying on hyper-fast glycolysis, to the astonishing ability to steal mitochondria from T-cells or poison them with damaged ones, cancer emerges as a metabolically cunning adversary. The episode concludes with a rapid review of the most compelling mitochondrial research from the past six months, including nanomaterials that supercharge stem-cell mitochondria, sprint training that breaks and rebuilds mitochondrial structure, the mitochondrial basis of T-cell memory and anti-tumor immunity, CRISPR tools revealing cancer’s metabolic vulnerabilities, mitochondrial drivers of sarcopenia, emerging blood biomarkers of mitochondrial aging, and groundbreaking three-parent IVF trials preventing inherited mitochondrial disease. It’s one of the most sweeping scientific episodes yet—revealing how mitochondrial medicine is rapidly reshaping our understanding of mental health, cancer, aging, and human vitality. Key Points: Mitochondrial dysfunction may cause anxiety and depression, not just correlate with them. Modifying MFN2 levels in neurons can erase or induce anxiety-like behavior in animals. Depression in humans is linked to higher mtDNA, shorter telomeres, and reduced ATP efficiency. Cancer cells disable apoptosis, favor fast glycolysis, and hijack mitochondria from immune cells. Cancer can poison T-cells with damaged mitochondria and hide them from autophagy. Nano-materials can stimulate stem cells to overproduce mitochondria and transfer them to damaged cells. Sprint interval training breaks down mitochondria initially but drives stronger remodeling and efficiency. T-cell immunity and anti-tumor responses rely heavily on mitochondrial metabolic flexibility. CRISPR mitochondrial knockout screens reveal key metabolic weaknesses in cancer. Sarcopenia is rooted in impaired mitophagy and dysfunctional mitochondrial dynamics. A new blood mitochondrial biomarker correlates with fitness, aging, and cognitive risk. Three-parent IVF using donor mitochondria can prevent inherited mitochondrial disease. Key Quotes from Dr. Mike “Mental disorders… are metabolic disorders of the brain, driven by mitochondria.” “Changes in the mitochondria impair communications between neurons, meaning treating the mitochondria may decrease the burden of psychiatric disorders.” “Those sneaky cancer cells literally suck the life out of the cells that come to fight them.” “Cancer cells not only steal mitochondria, they weaponize damaged ones to cripple the immune system.” “The future of mitochondrial medicine isn’t the future — it’s now.” Key Moments 00:00 – 00:03:36 Intro to the episode and setup for the discussion. 00:03:36 – 00:11:37 Psychiatric Disorders & Mitochondria — Reading from The Life Machines covering MFN2, anxiety/depression mechanisms, mtDNA changes, telomere shortening, ATP reduction, and the metabolic roots of mental illness. 00:11:37 – 00:13:17 Product update inserted into the episode (BioLithin / transition section). 00:13:17 – 00:22:15 Cancer & Mitochondria — How cancer evades apoptosis, relies on glycolysis, steals mitochondria, poisons immune cells, and adapts metabolically during metastasis. 00:22:15 – 00:23:19 Transition into recent mitochondrial research roundup. 00:23:19 – 00:25:07 Study 1: Nano-Flowers & Mitochondrial Biogenesis — Nanomaterials doubling mitochondrial output and transferring mitochondria to damaged cells. 00:25:07 – 00:28:05 Study 2: Sprint Interval Training — Mitochondrial breakdown → remodeling → improved oxidative function. 00:28:05 – 00:32:09 Study 3: T-Cell Mitochondrial Metabolism — T-cell memory, exhaustion, and antitumor immunity tied to mitochondrial flexibility. 00:32:09 – 00:34:07 Study 4: Mitochondrial Knockout CRISPR Library — Identifying cancer vulnerabilities in mitochondrial antioxidant pathways. 00:34:07 – 00:38:04 Study 5: Sarcopenia & Aging Muscle — Impaired mitophagy and dysfunctional mitochondrial dynamics driving muscle loss. 00:38:04 – 00:41:10 Study 6: Blood-Based Mitochondrial Biomarkers — Links to VO₂ max, aging,